{ "TCGA-BK-A0CB": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "59e9029a-8ddd-4447-b35a-72bc39f82a30", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1092", "DAYS_TO_BIRTH": -21930.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 111.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.90097643, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.90097643, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.90097643, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.90097643, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BK-A0CB-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2778, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 37, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "506-596", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3216.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 37, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "150", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 900.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11V": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d3c83c5e-acb1-4cb0-8f56-96341822582f", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "595", "DAYS_TO_BIRTH": -23630.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/4/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.56142946, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.56142946, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.56142946, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.56142946, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11V-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2837, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-AJ-A3OJ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "76F98002-E8DF-4DFA-926E-8BB2D5114966", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "467", "DAYS_TO_BIRTH": -19826.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 104.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.3532564, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.3532564, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.3532564, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.3532564, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3OJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8896, "MSI_SENSOR_SCORE": 21.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 29.83333333, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 81, "STOP_DATE": 230.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 81, "STOP_DATE": 230.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 233, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 274, "STOP_DATE": 286.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A1C8": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "bad34c92-1e64-4187-a0b4-061105fd13ba", "AGE": 77.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "776", "DAYS_TO_BIRTH": -28452.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.51204918, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.51204918, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.51204918, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1C8-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2994, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 285.0 }, "treatments": [] }, "TCGA-AX-A2HJ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "32398808-C46A-41BF-A0A8-E08723B40EA2", "AGE": 35.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "935", "DAYS_TO_BIRTH": -13112.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 56.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.73938916, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.73938916, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.73938916, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.73938916, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2HJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.1152, "MSI_SENSOR_SCORE": 26.9, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 53.1, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 10.0 }, "treatments": [ { "START_DATE": 326, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 274, "STOP_DATE": 330.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0LG": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "cca5717d-226d-4390-a99b-c7aed6d9d70e", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "2015", "DAYS_TO_BIRTH": -20047.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.24584936, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.24584936, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 66.24584936, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.24584936, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LG-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7979, "MSI_SENSOR_SCORE": 24.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.83333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 83, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0LD": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1200c8b7-a058-4c01-bbe2-04ec09a65245", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "3589", "DAYS_TO_BIRTH": -23216.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 117.9932275, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 117.9932275, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 117.9932275, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 117.9932275, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LD-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.0367, "MSI_SENSOR_SCORE": 34.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.86666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 101, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A1GR": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "70cdb758-26c9-4c11-a495-0c31cbc84949", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "536", "DAYS_TO_BIRTH": -24784.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.62172469, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.62172469, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.62172469, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.62172469, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GR-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.281, "MSI_SENSOR_SCORE": 0.58, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 209.0 }, "treatments": [] }, "TCGA-AP-A054": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d77e4dbc-b239-4742-8cb7-efd427010d13", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23404.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 23.3093336, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 23.3093336, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 18.60801526, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 18.60801526, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A054-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.04, "MSI_SENSOR_SCORE": 31.98, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 36.26666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1920.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 64, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2868.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A1NS": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a79a4e56-09bf-4691-b7e0-81a9c2620d0f", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "43", "DAYS_TO_BIRTH": -19638.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 126.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.413683138, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.413683138, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.413683138, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.413683138, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A1NS-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5021, "MSI_SENSOR_SCORE": 4.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.766666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-KP-A3W4": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "62DF1BD8-23A8-4E52-A483-6895B2F02494", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23200.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 18.21349903, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 18.21349903, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.55330901, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-KP-A3W4-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "KP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3573, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "British Columbia Cancer Agency", "TBL_SCORE": 170.0 }, "treatments": [] }, "TCGA-BG-A0LW": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "68181bc9-aa8b-44ec-8601-564b30ea0561", "AGE": 47.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "566", "DAYS_TO_BIRTH": -17369.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/1/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 141.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.60801526, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.60801526, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.60801526, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.60801526, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0LW-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2465, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BG-A0MC": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "884fd57d-bd8e-40e7-82f6-0ba1c71101a9", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1263", "DAYS_TO_BIRTH": -27136.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 135.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 41.52283263, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 41.52283263, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 41.52283263, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 41.52283263, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0MC-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2669, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 11.0 }, "treatments": [] }, "TCGA-QF-A5YT": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E4BCCEA0-0104-40C4-9E3C-2AD7262D918E", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1215", "DAYS_TO_BIRTH": -20981.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/25/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.0", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 146.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.94476773, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.94476773, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 39.94476773, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.94476773, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-QF-A5YT-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "QF", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3502, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.233333333, "TISSUE_SOURCE_SITE": "BLN - Baylor", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 158, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 165, "STOP_DATE": 204.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 50.4, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 214, "STOP_DATE": 221.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 2.0, "RADIATION_DOSAGE": 11.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A06J": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "b6819b52-6f01-4011-9bd3-a1a00397e0c9", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "913", "DAYS_TO_BIRTH": -26000.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 119.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.01610941, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.01610941, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.01610941, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.01610941, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A06J-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2922, "MSI_SENSOR_SCORE": 0.64, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 107, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin + Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 73, "STOP_DATE": 87.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A06L": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f4a7f2ff-be76-48d3-9f59-9223db33680e", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1845", "DAYS_TO_BIRTH": -23294.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/17/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 112.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 60.65686951, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 60.65686951, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 60.65686951, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 60.65686951, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A06L-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2699, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-D1-A1O7": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "01ed791e-3187-4e24-a5ff-afff0778c152", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "32", "DAYS_TO_BIRTH": -22037.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 96.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.052043265, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.052043265, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.052043265, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.052043265, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A1O7-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6161, "MSI_SENSOR_SCORE": 5.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.96666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-BS-A0TA": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ad3d8420-f562-4cbe-ac82-c968bd4f782d", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "714", "DAYS_TO_BIRTH": -21505.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Native Hawaiian or Other Pacific Islander", "RADIATION_THERAPY": "Yes", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 24.32850051, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 24.32850051, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.9532827, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0TA-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5657, "MSI_SENSOR_SCORE": 19.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 15.93333333, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 455, "STOP_DATE": 554.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "50", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": 300.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 29, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1050.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 455, "STOP_DATE": 561.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 240.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 29, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "621", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3726.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 599, "STOP_DATE": 613.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 3.0, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 189, "STOP_DATE": 241.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 29.0, "RADIATION_DOSAGE": 6100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Combination", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 407, "STOP_DATE": 423.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 13.0, "RADIATION_DOSAGE": 3900.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-KP-A3VZ": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6B35A816-F9C4-44D4-9824-5DEE4804B80D", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "722", "DAYS_TO_BIRTH": -25366.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 55.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.73672617, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.73672617, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.73672617, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-KP-A3VZ-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "KP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3111, "MSI_SENSOR_SCORE": 0.55, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "British Columbia Cancer Agency", "TBL_SCORE": 350.0 }, "treatments": [] }, "TCGA-B5-A0K8": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "24118b8f-59fe-482a-aed3-7b1bde1571b7", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "847", "DAYS_TO_BIRTH": -25992.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.84627018, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.84627018, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.84627018, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.84627018, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0K8-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3173, "MSI_SENSOR_SCORE": 0.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 215.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 74, "STOP_DATE": 200.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-5S-A9Q8": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8751429B-4A11-451E-B978-DC9E9DB0EB36", "AGE": 51.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "313", "DAYS_TO_BIRTH": -18785.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/23/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 86.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.29029819, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.29029819, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.29029819, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.29029819, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-5S-A9Q8-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "5S", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3199, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "Holy Cross", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 33, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 33, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 186, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11Y": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "c0db966b-1024-4ee3-899a-f12e3c71a42c", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "560", "DAYS_TO_BIRTH": -21860.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8382/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.41075714, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.41075714, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.41075714, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.41075714, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11Y-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4514, "MSI_SENSOR_SCORE": 3.92, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 31.7, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-D1-A165": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9bc2f33f-3067-4000-bc8a-1c5bb671d101", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "20", "DAYS_TO_BIRTH": -23526.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.657527041, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.657527041, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.657527041, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.657527041, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A165-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2651, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-BG-A3PP": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9F92080F-F6E0-42DB-A02B-B3069664F6D0", "AGE": 82.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "681", "DAYS_TO_BIRTH": -30227.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/2/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.38879574, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.38879574, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 21.86277411, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A3PP-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2949, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.033333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 249.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 186.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 74, "STOP_DATE": 186.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 238, "STOP_DATE": 253.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 11.0, "RADIATION_DOSAGE": 19.8, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11O": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a59a79fd-433d-44dc-9601-4c63d599ab28", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2609", "DAYS_TO_BIRTH": -22720.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 114.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 85.77440247, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 85.77440247, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 85.77440247, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 63.25410133, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11O-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2876, "MSI_SENSOR_SCORE": 0.56, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.2, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-A5-A1OG": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5c3f826c-b447-457d-a90e-715bad3c7118", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "348", "DAYS_TO_BIRTH": -23956.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 31.98869054, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 31.98869054, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 11.07933064, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.07933064, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-A5-A1OG-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.329, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 272.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": 152.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1800.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 48, "STOP_DATE": 48.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 417.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 69, "STOP_DATE": 152.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2505.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 179, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5050.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 223, "STOP_DATE": 238.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DI-A2QT": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "EE932B34-0114-41DC-B119-210C0ED84BCB", "AGE": 51.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -18835.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "American Indian or Alaska Native", "RADIATION_THERAPY": null, "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 12.39438472, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 12.39438472, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.39438472, "GENETIC_ANCESTRY_LABEL": "AMR" }, "sample": { "SAMPLE_ID": "TCGA-DI-A2QT-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3099, "MSI_SENSOR_SCORE": 0.43, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.733333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 182.0 }, "treatments": [] }, "TCGA-B5-A1MX": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "37bac6ba-be93-42cc-892b-efd0bdb850bd", "AGE": 47.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1473", "DAYS_TO_BIRTH": -17320.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.42686656, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.42686656, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 48.42686656, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.42686656, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A1MX-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8573, "MSI_SENSOR_SCORE": 16.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 191.2666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 83, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 39, "STOP_DATE": 80.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 42.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DF-A2KN": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "D438C58E-F038-47A3-8E62-485A5ACA9695", "AGE": null, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "67", "DAYS_TO_BIRTH": null, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": null, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/7/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": 77.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.202715587, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.202715587, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.202715587, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.202715587, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DF-A2KN-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DF", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8466, "MSI_SENSOR_SCORE": 19.89, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 146.1666667, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research", "TBL_SCORE": 28.0 }, "treatments": [] }, "TCGA-PG-A7D5": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4ADC20D7-5AF1-4126-9073-C7D7AE465D92", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1177", "DAYS_TO_BIRTH": -23006.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.69546635, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.69546635, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.69546635, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-PG-A7D5-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3506, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Montefiore Medical Center", "TBL_SCORE": 266.0 }, "treatments": [ { "START_DATE": 60, "STOP_DATE": 192.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin + Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 108, "STOP_DATE": 108.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 15.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 108, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 1.8, "RADIATION_DOSAGE": 45.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A3AV": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "D383008A-A1BF-4689-B243-3C464C79B818", "AGE": 51.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1069", "DAYS_TO_BIRTH": -18713.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 45.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.14482033, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.14482033, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.14482033, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.14482033, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-EO-A3AV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2853, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 137.1, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 10.0 }, "treatments": [ { "START_DATE": 96, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 96, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 232, "STOP_DATE": 267.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A0ZV": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0c01c673-e396-47b2-9562-4144d7705ebf", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "728", "DAYS_TO_BIRTH": -21374.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 77.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.93398429, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.93398429, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.93398429, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.93398429, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A0ZV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2787, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-AX-A06F": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f17e446a-c145-45be-8335-a856acb0b9b8", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1748", "DAYS_TO_BIRTH": -21624.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 57.46786337, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 57.46786337, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 57.46786337, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A06F-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3375, "MSI_SENSOR_SCORE": 3.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 243.5666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 20.0 }, "treatments": [ { "START_DATE": 76, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3755.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 76, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1630.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-PG-A6IB": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E8C7195B-A26B-4D98-B1C5-0AA18385E9C8", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "648", "DAYS_TO_BIRTH": -24969.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/5/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.30387612, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.30387612, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.30387612, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.30387612, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-PG-A6IB-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6358, "MSI_SENSOR_SCORE": 9.83, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.6, "TISSUE_SOURCE_SITE": "Montefiore Medical Center", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-D1-A2G6": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "46CD8DED-F8A1-4F8C-A4C2-2D5B51C04F18", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -19547.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 8.482098826, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 8.482098826, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.482098826, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A2G6-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3306, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 10.0 }, "treatments": [] }, "TCGA-DI-A1BU": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "53245616-e095-4616-89bb-6062669122da", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1195", "DAYS_TO_BIRTH": -20114.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.28724069, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.28724069, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 39.28724069, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.28724069, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DI-A1BU-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.991, "MSI_SENSOR_SCORE": 38.69, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 256.0333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 131, "STOP_DATE": 250.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "2100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2100.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 131, "STOP_DATE": 250.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "3550", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3550.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 123, "STOP_DATE": 132.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DI-A1NO": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d3e93d76-6565-454a-a085-4492024350e9", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24996.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 122.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 9.369760331, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 9.369760331, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.369760331, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DI-A1NO-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3418, "MSI_SENSOR_SCORE": 2.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.733333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 285.0 }, "treatments": [] }, "TCGA-PG-A915": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "EA95897E-3FE0-4C79-B170-88B0F229794C", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "249", "DAYS_TO_BIRTH": -22119.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/25/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8461/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 8.186211658, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.186211658, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.186211658, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.186211658, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-PG-A915-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3462, "MSI_SENSOR_SCORE": 0.42, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.433333333, "TISSUE_SOURCE_SITE": "Montefiore Medical Center", "TBL_SCORE": 318.0 }, "treatments": [] }, "TCGA-AP-A1DV": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1b685c46-57b3-4052-b5b9-1f704809bf04", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "204", "DAYS_TO_BIRTH": -21901.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 46.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 6.706775816, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.706775816, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 6.706775816, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.706775816, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1DV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3398, "MSI_SENSOR_SCORE": 0.7, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 404.6, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-B5-A121": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "19511f9e-7b0e-4a06-998d-c1837d37c6ec", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "504", "DAYS_TO_BIRTH": -21018.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.56968143, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.56968143, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.56968143, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.56968143, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A121-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2653, "MSI_SENSOR_SCORE": 0.13, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 54, "STOP_DATE": 102.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A2HC": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "53E8E07E-18F9-4C9B-9783-A5B67CEDDCF7", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1044", "DAYS_TO_BIRTH": -19485.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 118.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.32291153, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.32291153, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 24.85452214, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 24.85452214, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2HC-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5408, "MSI_SENSOR_SCORE": 9.49, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 435.7, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 121, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 974, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 924, "STOP_DATE": 955.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A17N": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "001e0309-9c50-42b0-9e38-347883ee2cd3", "AGE": 46.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "46", "DAYS_TO_BIRTH": -17045.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 134.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.512312194, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.512312194, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.512312194, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.512312194, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17N-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2676, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-EY-A215": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "48ab48a5-30e7-4f2e-8d0f-9bad7b8dc7db", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "574", "DAYS_TO_BIRTH": -22076.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 49.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.87102607, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.87102607, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.87102607, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.87102607, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A215-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8962, "MSI_SENSOR_SCORE": 18.6, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 155.6333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 83, "STOP_DATE": 96.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FI-A2EW": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "93D6DF4A-AEA2-48C2-8B6A-4B3ECA0BF26F", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1462", "DAYS_TO_BIRTH": -26267.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 59.01305191, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 59.01305191, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 38.43245554, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 38.43245554, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2EW-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.322, "MSI_SENSOR_SCORE": 1.87, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.3, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 255.0 }, "treatments": [ { "START_DATE": 69, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 69, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1194, "STOP_DATE": 1273.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1194, "STOP_DATE": 1273.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1326, "STOP_DATE": 1369.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1369, "STOP_DATE": 1431.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Topotecan", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A16V": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8b19c8ac-68e6-4dc8-aec9-1556e62ca20f", "AGE": 78.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "43", "DAYS_TO_BIRTH": -28635.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 105.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 3.945162245, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.945162245, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 3.945162245, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.945162245, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16V-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2571, "MSI_SENSOR_SCORE": 0.9, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 29.0 }, "treatments": [] }, "TCGA-JU-AAVI": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3E41CF2F-3DE9-44C1-A819-BCE693BAF67D", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "236", "DAYS_TO_BIRTH": -22289.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 121.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.7532301, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.7532301, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 16.60255778, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 16.60255778, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-JU-AAVI-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "JU", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3208, "MSI_SENSOR_SCORE": 0.46, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "BLN - Baylor", "TBL_SCORE": 264.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": 109.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 159, "STOP_DATE": 229.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 159, "STOP_DATE": 229.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 82, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 27.0, "RADIATION_DOSAGE": 4860.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 130, "STOP_DATE": 137.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1800.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0GI": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3b21b47e-a15c-4b10-9702-62a14afdfb8c", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2682", "DAYS_TO_BIRTH": -23195.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/15/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 88.17437617, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 88.17437617, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 88.17437617, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 88.17437617, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GI-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5646, "MSI_SENSOR_SCORE": 14.54, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.36666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 78, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A3G1": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9CC1B44A-AC26-408D-B12B-084E982CCADF", "AGE": 84.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -31037.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 20.51484367, "DSS_STATUS": null, "DSS_MONTHS": 20.51484367, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.51484367, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3G1-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3099, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 138.0 }, "treatments": [] }, "TCGA-AX-A2HK": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6FA99AE9-1D72-455E-938E-0EC0D240F5A3", "AGE": 77.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -28316.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 2.958871684, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 2.958871684, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.958871684, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-AX-A2HK-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3002, "MSI_SENSOR_SCORE": 0.45, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 258.0 }, "treatments": [] }, "TCGA-A5-A1OK": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2fe46394-cfc5-44bb-81a9-e438a0126f5b", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "917", "DAYS_TO_BIRTH": -23179.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.14761482, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.14761482, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.14761482, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.14761482, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A1OK-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2684, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3612.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 63, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/ml", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2058.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 182, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A1Y5": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5f2f2e7a-8aec-4011-b261-0c5bc68da840", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "327", "DAYS_TO_BIRTH": -23251.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.91494888, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.91494888, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.91494888, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.91494888, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A1Y5-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3174, "MSI_SENSOR_SCORE": 0.44, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.433333333, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 245.0 }, "treatments": [ { "START_DATE": 280, "STOP_DATE": 283.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 5.5, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0MO": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "734ef97f-807c-480e-8df9-feaf041032d2", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1309", "DAYS_TO_BIRTH": -23287.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.03514482, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.03514482, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 43.03514482, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.03514482, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0MO-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.237, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A187": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0f59bb0a-135c-4793-b1a7-5ad5172ed82d", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "448", "DAYS_TO_BIRTH": -24099.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.72860571, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.72860571, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.72860571, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.72860571, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A187-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2921, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-FI-A2EX": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3878F58E-76BA-4480-A784-88505BD464D0", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "284", "DAYS_TO_BIRTH": -21489.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.336883979, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.336883979, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 7.002662985, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.002662985, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2EX-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3055, "MSI_SENSOR_SCORE": 0.44, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.133333333, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 404.0 }, "treatments": [ { "START_DATE": 38, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 38, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 213, "STOP_DATE": 274.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A1CK": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "45effb44-0b5f-4081-a202-d85969c72f2b", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2441", "DAYS_TO_BIRTH": -21200.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 80.25117533, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 80.25117533, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 80.25117533, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1CK-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2799, "MSI_SENSOR_SCORE": 0.54, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 8.0 }, "treatments": [] }, "TCGA-D1-A17K": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5c22c8d6-5805-455c-8e1c-e6b8006738e4", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "854", "DAYS_TO_BIRTH": -27283.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 97.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.07640464, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.07640464, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 26.79422691, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 26.79422691, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17K-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2804, "MSI_SENSOR_SCORE": 0.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 200.0 }, "treatments": [] }, "TCGA-EY-A1GO": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9370e189-8fb7-4bfa-8ef9-2220f3557188", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "586", "DAYS_TO_BIRTH": -23853.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.2655423, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.2655423, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 16.99707401, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 16.99707401, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GO-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4959, "MSI_SENSOR_SCORE": 3.82, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.766666667, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 11.0 }, "treatments": [ { "START_DATE": 25, "STOP_DATE": 250.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 25, "STOP_DATE": 250.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 552, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 157, "STOP_DATE": 159.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 540.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 152, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 540.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 109, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 3960.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 123, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 4", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DI-A1BY": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e46b6434-ee88-4630-9fc3-441afc431745", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1114", "DAYS_TO_BIRTH": -23113.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 125.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.62425617, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.62425617, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.62425617, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.62425617, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DI-A1BY-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2991, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 202, "STOP_DATE": 211.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11H": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "dee43082-4aa7-4650-981c-a779e9fe7b55", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2687", "DAYS_TO_BIRTH": -24556.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 101.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 88.33875793, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 88.33875793, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 88.33875793, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 88.33875793, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11H-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9954, "MSI_SENSOR_SCORE": 40.43, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 34.0, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 25.0 }, "treatments": [ { "START_DATE": 33, "STOP_DATE": 904.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A1DM": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ca7f9d8b-2abc-4606-bf95-4c42791b38bd", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1700", "DAYS_TO_BIRTH": -22239.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 92.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 55.88979847, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 55.88979847, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 55.88979847, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 55.88979847, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1DM-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6163, "MSI_SENSOR_SCORE": 13.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.0, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 133, "STOP_DATE": 154.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A1CA": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3ede5dff-8cf5-43e8-bf4b-e8ad75bf68ee", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "974", "DAYS_TO_BIRTH": -25817.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 77.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.02156689, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.02156689, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.02156689, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1CA-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 22.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3043, "MSI_SENSOR_SCORE": 0.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.6, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 171.0 }, "treatments": [ { "START_DATE": 114, "STOP_DATE": 274.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 114, "STOP_DATE": 274.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "adjuvent", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A1GL": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d46d5af5-62ae-43eb-a885-4c078e0c956e", "AGE": 51.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1014", "DAYS_TO_BIRTH": -18761.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.33662097, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.33662097, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.33662097, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.33662097, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GL-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2939, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 114, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 2.0, "RADIATION_DOSAGE": 1000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 62, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A18C": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "66e305ca-8a16-44f0-b837-85e529b7ad55", "AGE": 72.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "470", "DAYS_TO_BIRTH": -26602.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 96.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.45188546, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.45188546, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.45188546, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.45188546, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A18C-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2796, "MSI_SENSOR_SCORE": 2.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.6, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 55.0 }, "treatments": [] }, "TCGA-FI-A2D0": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1B35D083-F7C9-47D2-9A9E-718788F9E39A", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1023", "DAYS_TO_BIRTH": -20393.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 135.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.87901502, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.87901502, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 39.87901502, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.87901502, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2D0-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6227, "MSI_SENSOR_SCORE": 8.76, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 216.3666667, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BK-A0C9": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "92a2cae3-b8ee-4ebb-ac5c-01e58749448f", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1092", "DAYS_TO_BIRTH": -20876.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 127.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.90097643, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.90097643, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.90097643, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.90097643, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-BK-A0C9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5893, "MSI_SENSOR_SCORE": 19.92, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 19.63333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-D1-A17R": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "73a0dd38-115d-48fb-b683-04aa5d612f2a", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -21382.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 126.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.14508334, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.14508334, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.14508334, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.14508334, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17R-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4451, "MSI_SENSOR_SCORE": 9.94, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.366666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-AP-A1E0": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "84b96f93-6273-4101-a259-9602000ae491", "AGE": 40.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1832", "DAYS_TO_BIRTH": -14653.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 60.22947694, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 60.22947694, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 60.22947694, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 60.22947694, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1E0-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2856, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 162.4333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 75, "STOP_DATE": 183.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1680.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 75, "STOP_DATE": 183.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3900.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0GP": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0547cdfa-c488-4da0-9bb5-4cc63a637179", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1416", "DAYS_TO_BIRTH": -21365.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 46.55291449, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 46.55291449, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 46.55291449, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 46.55291449, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GP-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2524, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 48.86666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-B5-A11S": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "cfd096ac-4d0f-4b89-8822-00656bc7f516", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "2229", "DAYS_TO_BIRTH": -23085.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 118.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 73.2813887, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.2813887, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 73.2813887, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 1.347930434, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11S-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2571, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-AP-A1DR": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0f064588-2d7e-439a-90a6-dfa17bb8af15", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1495", "DAYS_TO_BIRTH": -21904.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 109.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 49.1501463, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 49.1501463, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 49.1501463, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 49.1501463, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1DR-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9916, "MSI_SENSOR_SCORE": 27.51, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 24.76666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 186, "STOP_DATE": 249.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1440.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 186, "STOP_DATE": 249.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "496", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1984.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 116, "STOP_DATE": 144.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 350.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 112, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A15V": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f7010b87-a559-4501-99f9-0fcca1e986e1", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "1201", "DAYS_TO_BIRTH": -24886.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 69.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.4844988, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.4844988, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 39.4844988, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 39.4844988, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A15V-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2688, "MSI_SENSOR_SCORE": 0.79, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 113.0 }, "treatments": [ { "START_DATE": 42, "STOP_DATE": 132.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2060.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 42, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1210.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 158, "STOP_DATE": 172.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A3AU": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8E225F5F-49C1-4A39-A8B5-41FEA6A79819", "AGE": 72.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1543", "DAYS_TO_BIRTH": -26406.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 78.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 50.7282112, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 50.7282112, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 50.7282112, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 38.7283427, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A3AU-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8955, "MSI_SENSOR_SCORE": 19.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 22.43333333, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-B5-A0K7": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2f0640bc-598c-4714-9e9b-7e0f2ca4567f", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1933", "DAYS_TO_BIRTH": -23429.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/20/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 63.54998849, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 63.54998849, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 10.58618536, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.58618536, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0K7-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2724, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 393, "STOP_DATE": 407.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 7500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0LT": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "43714e9a-e9c4-4206-af92-1d00d2a8ae35", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1497", "DAYS_TO_BIRTH": -21107.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 91.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 49.215899, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 49.215899, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 49.215899, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 49.215899, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LT-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.1312, "MSI_SENSOR_SCORE": 37.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.2, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 46, "STOP_DATE": 61.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0LE": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "dcff8659-ecca-4798-80a3-dd6e7642ba2b", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "3357", "DAYS_TO_BIRTH": -20967.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 110.3659138, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 110.3659138, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 110.3659138, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 110.3659138, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LE-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9987, "MSI_SENSOR_SCORE": 33.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 18.23333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 75, "STOP_DATE": 105.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0LQ": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "252500d2-86a3-4090-a57f-1e8c3d44c573", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "2457", "DAYS_TO_BIRTH": -21629.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 80.77719696, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 80.77719696, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 80.77719696, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 80.77719696, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LQ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2808, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 85, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EC-A1QX": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f17bb238-2651-48a5-9a47-5077218efe08", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "224", "DAYS_TO_BIRTH": -26259.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/3/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.364302857, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.364302857, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.199921097, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EC-A1QX-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EC", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6203, "MSI_SENSOR_SCORE": 7.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.53333333, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 220.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 320.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 61, "STOP_DATE": 220.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "1600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 6400.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 61, "STOP_DATE": 220.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "570", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2280.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 100, "STOP_DATE": 130.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 3740.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A2OP": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "F7165DEA-C528-44F3-954F-E111A3D77B4E", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "944", "DAYS_TO_BIRTH": -23090.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 57.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.03527633, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.03527633, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.03527633, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.03527633, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A2OP-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7773, "MSI_SENSOR_SCORE": 14.61, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 15.3, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-E6-A2P9": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "077BDC90-1BBD-49EC-93A5-729B1AC1BA8D", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1386", "DAYS_TO_BIRTH": -24088.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 125.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 45.56662393, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 45.56662393, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 45.56662393, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 45.56662393, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E6-A2P9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E6", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.0301, "MSI_SENSOR_SCORE": 20.99, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 29.03333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": 72.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3I9": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E5D64754-15E8-494E-B7F7-25CF2819FE4C", "AGE": 52.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "39", "DAYS_TO_BIRTH": -19139.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.06282671, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.06282671, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 12.16425026, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.16425026, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3I9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2895, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 116.0 }, "treatments": [ { "START_DATE": 379, "STOP_DATE": 456.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 379, "STOP_DATE": 456.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 127, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0V4": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e3f515f8-a940-40d1-86b0-baed0f410f2c", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1810", "DAYS_TO_BIRTH": -20777.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 96.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 59.50619719, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 59.50619719, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 59.50619719, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 59.50619719, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0V4-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6106, "MSI_SENSOR_SCORE": 6.86, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.8, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 14.0 }, "treatments": [] }, "TCGA-DI-A2QY": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6524A6D3-A9F0-4A46-AC0B-7BEB0CD1B915", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2797", "DAYS_TO_BIRTH": -23398.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/29/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 110.102903, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 110.102903, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 110.102903, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 110.102903, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DI-A2QY-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.301, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.666666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 263.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": 239.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 88, "STOP_DATE": 129.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0R9": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "284174fd-1320-4617-9e99-75bd75df9bf3", "AGE": 51.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "749", "DAYS_TO_BIRTH": -18982.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 145.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.62438768, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.62438768, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.62438768, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.62438768, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0R9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2815, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 124, "STOP_DATE": 136.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A23M": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d39df936-4bc6-404d-9e1d-f6416cc5a34c", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "36", "DAYS_TO_BIRTH": -22430.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 141.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 20.25183286, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 20.25183286, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 16.96419765, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A23M-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3253, "MSI_SENSOR_SCORE": 0.51, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.6, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 399.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": null, "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 184, "STOP_DATE": 215.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 215, "STOP_DATE": 243.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A214": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4125e3e5-51c0-4577-9935-10cd086fc415", "AGE": 66.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "438", "DAYS_TO_BIRTH": -24136.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 94.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.39984219, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.39984219, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.39984219, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.39984219, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A214-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2972, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 101.0 }, "treatments": [ { "START_DATE": 96, "STOP_DATE": 277.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 96, "STOP_DATE": 277.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 173, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A1DO": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3348a7aa-f5c3-4fba-9968-68da5cedfd7e", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "952", "DAYS_TO_BIRTH": -22787.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.29828714, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.29828714, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.29828714, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.29828714, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1DO-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8996, "MSI_SENSOR_SCORE": 26.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 18.63333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-D1-A0ZR": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0ce940f2-9eb1-4757-8f8f-147a4f3a1e67", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "17", "DAYS_TO_BIRTH": -21157.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 117.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.558897985, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.558897985, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.558897985, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.558897985, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A0ZR-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2979, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-EY-A1GP": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "75fb484d-cd12-4cf0-a99d-faf27aead118", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "573", "DAYS_TO_BIRTH": -20011.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.83814972, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.83814972, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.83814972, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.83814972, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GP-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3006, "MSI_SENSOR_SCORE": 0.5, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 15.0 }, "treatments": [] }, "TCGA-EO-A3L0": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "423DA953-30AA-4F7E-96B5-1F6FD24F8874", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1554", "DAYS_TO_BIRTH": -28003.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 110.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.08985107, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.08985107, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.08985107, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.08985107, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A3L0-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2865, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.5, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 202, "STOP_DATE": 206.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 21.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A1MU": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f5261330-596e-4632-a5a3-8d3a2aa5de38", "AGE": 79.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -29027.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 44.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 50.89259296, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 50.89259296, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 44.87622054, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A1MU-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3022, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 106.0 }, "treatments": [ { "START_DATE": 1399, "STOP_DATE": 1550.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0VW": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "62d71839-4fba-42e9-9929-8d937f0fe287", "AGE": 77.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1582", "DAYS_TO_BIRTH": -28383.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.01038893, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.01038893, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 52.01038893, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.01038893, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0VW-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5605, "MSI_SENSOR_SCORE": 18.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.7, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-B5-A0JV": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "233e947a-d5e2-48e5-a8ce-5da1abb20681", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2616", "DAYS_TO_BIRTH": -23295.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "12/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 94.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.00453694, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.00453694, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 22.94769372, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 22.94769372, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0JV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6077, "MSI_SENSOR_SCORE": 22.81, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.53333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 34.0 }, "treatments": [ { "START_DATE": 41, "STOP_DATE": 48.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A3FC": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "EC2040A3-788B-4F2C-A093-C5C4B3DC4B6C", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2185", "DAYS_TO_BIRTH": -19422.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/23/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.83482921, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.83482921, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 71.83482921, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A3FC-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6869, "MSI_SENSOR_SCORE": 24.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 410.1666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 45.0 }, "treatments": [] }, "TCGA-DF-A2L0": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7ADAF608-19A5-4184-8B79-BBC6F9CF24AE", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22200.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": null, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 25.90656541, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 25.90656541, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 17.19433212, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.19433212, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DF-A2L0-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DF", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3109, "MSI_SENSOR_SCORE": 0.67, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research", "TBL_SCORE": 78.0 }, "treatments": [ { "START_DATE": 98, "STOP_DATE": 201.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 98, "STOP_DATE": 201.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 565, "STOP_DATE": 607.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Clinical Trial", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 228, "STOP_DATE": 263.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A176": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6d061ca9-ba7e-4b82-ab3c-34e33f244a54", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "917", "DAYS_TO_BIRTH": -24521.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 94.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.14761482, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.14761482, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.14761482, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.14761482, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A176-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6796, "MSI_SENSOR_SCORE": 19.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.66666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 19.0 }, "treatments": [] }, "TCGA-FI-A2D6": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "787D313F-9255-4B93-8AC2-0AA8FEBB7909", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "263", "DAYS_TO_BIRTH": -27060.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 25.21616202, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.21616202, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.21616202, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.21616202, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2D6-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.1265, "MSI_SENSOR_SCORE": 22.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.23333333, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-EO-A22R": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "508BF716-46F9-44DC-8E39-09261DFB073E", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1878", "DAYS_TO_BIRTH": -20604.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.74178913, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.74178913, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.74178913, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.74178913, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A22R-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3971, "MSI_SENSOR_SCORE": 2.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 429.5666667, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 76, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 45.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-SJ-A6ZJ": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "FBFED398-2A44-44A9-83CF-657C29CB7D28", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "556", "DAYS_TO_BIRTH": -22597.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 132.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.27925173, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.27925173, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.27925173, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.27925173, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-SJ-A6ZJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "SJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3382, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 205, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 21.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0V7": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ca858743-1f06-40e3-accf-395d08375b63", "AGE": 48.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1934", "DAYS_TO_BIRTH": -17810.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Native Hawaiian or Other Pacific Islander", "RADIATION_THERAPY": "No", "WEIGHT": 102.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 63.58286485, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 63.58286485, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 63.58286485, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 63.58286485, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0V7-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2599, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.0, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-D1-A0ZN": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "916ccf0d-02ef-4ccb-824b-6b4294095a08", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "512", "DAYS_TO_BIRTH": -22026.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/4/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.83269224, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.83269224, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.83269224, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 14.72860571, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A0ZN-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2645, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 463, "STOP_DATE": 497.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": "Left Breast Cancer", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 850.0, "RADIATION_DOSAGE": 5000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A2QN": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E00F6DC5-BC8B-472D-BAC3-C7823364F01E", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1069", "DAYS_TO_BIRTH": -21915.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 132.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.14482033, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.14482033, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.14482033, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.14482033, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A2QN-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2877, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 23.0 }, "treatments": [] }, "TCGA-D1-A17A": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "c68dd983-b199-4f53-ac0c-b2d8dd6a7931", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "48", "DAYS_TO_BIRTH": -21560.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 102.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.578064898, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.578064898, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.578064898, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.578064898, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17A-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5402, "MSI_SENSOR_SCORE": 12.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.133333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 16.0 }, "treatments": [] }, "TCGA-AJ-A3BK": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "503E6C30-1B62-4F85-BCB4-E34C009894AB", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1031", "DAYS_TO_BIRTH": -24943.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 92.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.89551895, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.89551895, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.89551895, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.89551895, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3BK-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2952, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 137, "STOP_DATE": 168.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EC-A1NJ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "b3aa16d6-1677-445d-a8d3-46657d4f8b43", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "488", "DAYS_TO_BIRTH": -27002.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.0436598, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.0436598, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.0436598, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.0436598, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EC-A1NJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EC", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4662, "MSI_SENSOR_SCORE": 3.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.566666667, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-QS-A8F1": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "54AC877A-52FF-450C-9DF9-B7CD3FC8E2E2", "AGE": 85.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "125", "DAYS_TO_BIRTH": -31386.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/13/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.3", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 4.438307525, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 4.438307525, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.438307525, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-QS-A8F1-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "QS", "TUMOR_TISSUE_SITE": "Other", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3647, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 237.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 62.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 62, "STOP_DATE": 62.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0L9": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7b9947d5-e86b-4006-8890-ea5209584a88", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "3815", "DAYS_TO_BIRTH": -26185.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 125.423283, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 125.423283, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 125.423283, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 125.423283, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0L9-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3048, "MSI_SENSOR_SCORE": 1.98, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 371.0 }, "treatments": [] }, "TCGA-EY-A1GW": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f8ac5fd2-11f2-4b3a-a3a6-ff1a6d8e1cae", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "260", "DAYS_TO_BIRTH": -26979.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.07933064, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 11.07933064, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.246506888, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GW-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2974, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.833333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 90.0 }, "treatments": [ { "START_DATE": 40, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "131", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1425.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 40, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2560.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 225, "STOP_DATE": 288.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A16G": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "16e69011-c295-479f-b521-86e66fba498d", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27065.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 27.4188776, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 27.4188776, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 21.10661801, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16G-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2742, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 149.0 }, "treatments": [ { "START_DATE": 651, "STOP_DATE": 756.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "135", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 3.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1470.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 794, "STOP_DATE": 822.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 4.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 145.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 91, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2730.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 91, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1600.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 67, "STOP_DATE": 67.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 480.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 67, "STOP_DATE": 67.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "135", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 250.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 651, "STOP_DATE": 756.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 3.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2770.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 243, "STOP_DATE": 250.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 2.0, "RADIATION_DOSAGE": 1100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 220, "STOP_DATE": 257.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A163": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a438dce7-6592-4ea6-a401-57f5a8fe8ba6", "AGE": 50.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "991", "DAYS_TO_BIRTH": -18604.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 109.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.58046487, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.58046487, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 7.331426505, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.331426505, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A163-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9412, "MSI_SENSOR_SCORE": 29.96, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 19.03333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 351, "STOP_DATE": 498.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 5360.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 343, "STOP_DATE": 498.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2490.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 74, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 110, "STOP_DATE": 110.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 1.0, "RADIATION_DOSAGE": 500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 249, "STOP_DATE": 281.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 327, "STOP_DATE": 327.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 4", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 1.0, "RADIATION_DOSAGE": 1000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A1GQ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8636db4d-a67b-4d8a-b02f-15fce553cf17", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "544", "DAYS_TO_BIRTH": -27905.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.88473551, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.88473551, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 10.98070158, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.98070158, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GQ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6634, "MSI_SENSOR_SCORE": 13.42, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 15.36666667, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 377, "STOP_DATE": 503.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 377, "STOP_DATE": 503.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 112, "STOP_DATE": 124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0RA": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "afd710b8-d172-4ac4-9973-e969db1ed231", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "884", "DAYS_TO_BIRTH": -25060.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 113.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.0626952, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.0626952, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.0626952, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.0626952, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0RA-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2688, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 99, "STOP_DATE": 151.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A1NX": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "df01a5ee-e8b5-40b0-8a6a-b6b3faed9df9", "AGE": 66.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "555", "DAYS_TO_BIRTH": -24441.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.24637538, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.24637538, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 15.64914357, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 15.64914357, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A1NX-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3074, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 231.0 }, "treatments": [ { "START_DATE": 56, "STOP_DATE": 159.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1980.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 56, "STOP_DATE": 159.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3060.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 519, "STOP_DATE": 534.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 12.0, "RADIATION_DOSAGE": 8400.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 195, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 2.0, "RADIATION_DOSAGE": 1000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 180, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A0K4": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a8f38e37-978b-4435-b676-e8d4c34da909", "AGE": 51.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1757", "DAYS_TO_BIRTH": -18631.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 57.76375053, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 57.76375053, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 57.76375053, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 57.76375053, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0K4-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2551, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 165.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "645", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 62, "STOP_DATE": 165.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "310", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 189, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 2500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A16Q": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7f4f3aed-69af-421e-817b-b258dcc0bac5", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "324", "DAYS_TO_BIRTH": -19873.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 117.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.65193806, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.65193806, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.65193806, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.65193806, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16Q-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2458, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 8.0 }, "treatments": [] }, "TCGA-D1-A1NY": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0a9faff7-ec4d-4b5a-aa83-6fa358f72074", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "513", "DAYS_TO_BIRTH": -24683.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 97.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.8655686, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.8655686, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.8655686, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.8655686, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A1NY-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9023, "MSI_SENSOR_SCORE": 20.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 19.3, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 9.0 }, "treatments": [ { "START_DATE": 37, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3620.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 37, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2220.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 52, "STOP_DATE": 60.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A22S": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8F2D3495-8CE7-4F6E-A41D-8CFAE5750937", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1872", "DAYS_TO_BIRTH": -21328.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.54453102, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.54453102, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.54453102, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.54453102, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A22S-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9162, "MSI_SENSOR_SCORE": 21.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.23333333, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-D1-A16X": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "22618073-4ef0-4c3a-97b9-90ba1caa1d72", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "111", "DAYS_TO_BIRTH": -19799.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 101.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 3.649275076, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.649275076, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 3.649275076, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.649275076, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16X-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2756, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 91.3, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-DF-A2KU": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "95EEFB47-3F96-4A6D-8773-4D22843F0A6A", "AGE": null, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "3067", "DAYS_TO_BIRTH": null, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": null, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 100.8317717, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 100.8317717, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 100.8317717, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 100.8317717, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DF-A2KU-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DF", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3546, "MSI_SENSOR_SCORE": 0.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 337.6666667, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 212, "STOP_DATE": 251.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A2QO": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "DCF1BEB9-BCE4-4F4C-98DD-1226D8E0C125", "AGE": 85.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "92", "DAYS_TO_BIRTH": -31222.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 67.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 34.35578788, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.35578788, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.35578788, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.35578788, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A2QO-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.104, "MSI_SENSOR_SCORE": 29.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 37.96666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-A5-A0GM": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "976bb47a-d999-4e24-ad08-452fea73c846", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1841", "DAYS_TO_BIRTH": -19452.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/15/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 97.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 60.52536411, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 60.52536411, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 60.52536411, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 60.52536411, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GM-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2497, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-AP-A5FX": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "A633D316-59A4-45AE-8BF8-135CFBD27656", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1026", "DAYS_TO_BIRTH": -25063.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/26/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8255/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 36.13111089, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 36.13111089, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 13.38067528, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 13.38067528, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AP-A5FX-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2855, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 412.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 84, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 273, "STOP_DATE": 305.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A3DA": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E17A5FCA-616C-4A74-ABE7-778539ECDC0B", "AGE": 77.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "483", "DAYS_TO_BIRTH": -28142.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 57.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.87927804, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.87927804, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.87927804, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.87927804, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A3DA-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3098, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.5, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 21.0 }, "treatments": [ { "START_DATE": 50, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 56, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3NG": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1ADDCD66-79AB-4976-9679-37F0F31BA1DF", "AGE": 83.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "475", "DAYS_TO_BIRTH": -30351.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/17/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.61626722, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.61626722, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.61626722, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.61626722, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3NG-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3693, "MSI_SENSOR_SCORE": 0.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.466666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 10.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 148, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0TD": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ffaa98a0-2b69-46dc-aee5-c5c3f2abbc38", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2379", "DAYS_TO_BIRTH": -23950.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.9", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 78.2128415, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 78.2128415, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 78.2128415, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 78.2128415, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0TD-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2691, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-B5-A1MW": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E2B48D0D-57CA-400B-8598-55EF132E350E", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "447", "DAYS_TO_BIRTH": -20183.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.69572936, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.69572936, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 10.22454548, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.22454548, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A1MW-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8113, "MSI_SENSOR_SCORE": 13.94, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 18.03333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 349, "STOP_DATE": 381.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 33.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 388, "STOP_DATE": 401.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Radioisotope", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0MT": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "082e32c5-7f82-466a-b52d-a3293a8f8e57", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "644", "DAYS_TO_BIRTH": -23574.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.17237071, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.17237071, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 18.5751389, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0MT-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2661, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 38.0 }, "treatments": [] }, "TCGA-FI-A2F9": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "25E7D9D6-7381-40E1-B7ED-1D8C936B7C5C", "AGE": 79.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1803", "DAYS_TO_BIRTH": -28886.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 99.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 59.27606273, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 59.27606273, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 59.27606273, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 59.27606273, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2F9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3153, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 380.0 }, "treatments": [ { "START_DATE": 85, "STOP_DATE": 116.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 2500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11U": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0b672aa4-fc13-476f-b61e-5f2c3a615c23", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "509", "DAYS_TO_BIRTH": -27160.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.73406319, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.73406319, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.73406319, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11U-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7585, "MSI_SENSOR_SCORE": 27.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.3, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-A5-A0GH": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "32e33897-29c8-48f2-b833-98f37204e0e7", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "2254", "DAYS_TO_BIRTH": -21090.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/13/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 55.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 74.1032975, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 74.1032975, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 74.1032975, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 74.1032975, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GH-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9762, "MSI_SENSOR_SCORE": 30.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.36666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-D1-A1O8": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "21faf1a4-f6d3-4cc6-a49a-04b8541ef598", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25789.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 3.945162245, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.945162245, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 3.945162245, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.945162245, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A1O8-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2803, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BK-A0CA": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "51bd85e2-2c60-4654-bfcb-83dccef8964b", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1064", "DAYS_TO_BIRTH": -22378.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.98043857, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.98043857, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.98043857, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.98043857, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BK-A0CA-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3061, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.633333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 11.3 }, "treatments": [ { "START_DATE": 93, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": 7.0, "PRESCRIBED_DOSE": "108", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 756.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 93, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 7.0, "PRESCRIBED_DOSE": "428-572", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3329.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-SL-A6JA": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2A19051E-3AD1-444A-9D02-F895C26AC02C", "AGE": 77.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "7", "DAYS_TO_BIRTH": -28401.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 129.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.230134464, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.230134464, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.230134464, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.230134464, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-SL-A6JA-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "SL", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9515, "MSI_SENSOR_SCORE": 26.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 25.06666667, "TISSUE_SOURCE_SITE": "St. Joseph's Hospital AZ", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-A5-A0GJ": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "94817e78-78f5-4556-9394-610df65605e2", "AGE": 44.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "2000", "DAYS_TO_BIRTH": -16421.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/17/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 115.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 65.75270408, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 65.75270408, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 0.394516225, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 0.394516225, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2959, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 152.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3560.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 49, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1460.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0U7": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "282ddc43-922d-4f1f-80c7-6ba2de23b7bc", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23166.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 30.73938916, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.73938916, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.73938916, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.73938916, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0U7-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3873, "MSI_SENSOR_SCORE": 3.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.2, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-B5-A11G": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d2aa7d70-a25f-4a9e-9d52-37e372461824", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "3448", "DAYS_TO_BIRTH": -25995.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 77.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 113.3576618, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 113.3576618, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 113.3576618, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 113.3576618, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11G-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.862, "MSI_SENSOR_SCORE": 28.95, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 18.53333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 24.0 }, "treatments": [] }, "TCGA-B5-A11I": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f6d136c7-c250-4361-9fed-50f513959a40", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2303", "DAYS_TO_BIRTH": -23857.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8140/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 124.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 75.71423875, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 75.71423875, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 23.17782819, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11I-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2907, "MSI_SENSOR_SCORE": 1.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.633333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 168.0 }, "treatments": [ { "START_DATE": 742, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "20", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 714, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 63, "STOP_DATE": 256.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "350", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 63, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "350", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1967, "STOP_DATE": 1993.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 19.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 151, "STOP_DATE": 186.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A2H2": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E4510C66-A60B-4B09-A4E8-74EC5B26A3A5", "AGE": 86.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -31524.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 4.767071046, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 4.767071046, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 4.767071046, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 4.767071046, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2H2-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.292, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.233333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 599.0 }, "treatments": [] }, "TCGA-BG-A0MA": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "F85BC60B-AB07-4B24-820B-6860B198E910", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22036.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 111.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.71769077, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 10.71769077, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 2.301344643, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0MA-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2841, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-D1-A17C": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6f4f0cdd-8387-45d0-a9e8-efce6260159d", "AGE": 78.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "30", "DAYS_TO_BIRTH": -28571.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.986290561, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.986290561, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.986290561, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.986290561, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17C-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2689, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-D1-A3DG": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7890628D-7120-4DBC-85AE-1F895B6660C2", "AGE": 81.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "130", "DAYS_TO_BIRTH": -29771.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 86.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 4.273925765, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 4.273925765, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 4.273925765, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A3DG-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2964, "MSI_SENSOR_SCORE": 0.66, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.2, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 118.0 }, "treatments": [] }, "TCGA-D1-A1O5": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f054a123-322f-444a-9971-53d3df371753", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "458", "DAYS_TO_BIRTH": -22580.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.05736923, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.05736923, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.05736923, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.05736923, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A1O5-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2812, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.133333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-A5-A3LP": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9BECF65D-01F2-4E84-A256-106002E22526", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "455", "DAYS_TO_BIRTH": -27131.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 46.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.95874018, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.95874018, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.95874018, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.95874018, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A3LP-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3022, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.633333333, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 245.0 }, "treatments": [ { "START_DATE": 106, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0M4": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "73e5310d-ba8c-4cbc-aa4f-e06206f898f4", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2167", "DAYS_TO_BIRTH": -22090.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/1/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 97.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.24305487, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.24305487, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 71.24305487, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 71.24305487, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0M4-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8536, "MSI_SENSOR_SCORE": 28.95, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 19.5, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 95, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 95, "STOP_DATE": 170.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-QS-A744": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8E8F19BD-DBAA-4738-BAD2-207F634CD63D", "AGE": 86.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "451", "DAYS_TO_BIRTH": -31520.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.0", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.0", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.82723477, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.82723477, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.82723477, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-QS-A744-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "QS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3346, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 143, "STOP_DATE": 220.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 143, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A1DQ": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ad0806a5-df9e-48ea-bc8b-d4a3c9ea7ea0", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1276", "DAYS_TO_BIRTH": -27815.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 46.78304895, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 46.78304895, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 29.7530986, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 29.7530986, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1DQ-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3125, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.966666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 151.0 }, "treatments": [ { "START_DATE": 150, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 420.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 924, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 941, "STOP_DATE": 961.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 14.0, "RADIATION_DOSAGE": 3500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A2K4": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "C4F8F33F-A07C-4DFB-BE24-C52D577BD640", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25270.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 51.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 28.63530263, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 28.63530263, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 17.35871388, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.35871388, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A2K4-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 30.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2858, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 326.0 }, "treatments": [ { "START_DATE": 555, "STOP_DATE": 561.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 700.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 23, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1431.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 555, "STOP_DATE": 561.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": "30", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 96.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 23, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2245.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 611, "STOP_DATE": 821.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 9.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 3.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2430.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A0ZZ": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4d3af3af-24f4-415a-9677-20b0f366a102", "AGE": 80.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "686", "DAYS_TO_BIRTH": -29420.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 51.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.5531775, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.5531775, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.5531775, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.5531775, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-D1-A0ZZ-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3019, "MSI_SENSOR_SCORE": 1.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 267.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 780.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 61, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1690.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 109, "STOP_DATE": 116.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DF-A2KR": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "30B62630-FC6D-4620-874A-1E15FD4F40EA", "AGE": 84.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "2178", "DAYS_TO_BIRTH": -31007.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": null, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/14/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.60469474, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.60469474, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 71.60469474, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 69.46773186, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DF-A2KR-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DF", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3419, "MSI_SENSOR_SCORE": 0.58, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.1, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research", "TBL_SCORE": 208.0 }, "treatments": [ { "START_DATE": 98, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A1GT": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e0d13e2d-cf48-4b66-bfc2-88f872f67d79", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "490", "DAYS_TO_BIRTH": -25151.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 70.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.1094125, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.1094125, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.1094125, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.1094125, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GT-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2756, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.6, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-AP-A051": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "b045f24b-f822-4df9-9ffa-47308edcec8c", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "3948", "DAYS_TO_BIRTH": -25269.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 97.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 129.7958379, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 129.7958379, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 129.7958379, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 129.7958379, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A051-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6799, "MSI_SENSOR_SCORE": 30.46, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 278.0, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 80, "STOP_DATE": 117.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A16Y": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0e9c36fd-2d5d-48da-8364-f8c5edc3d873", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "532", "DAYS_TO_BIRTH": -20455.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.49021929, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.49021929, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.49021929, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.49021929, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16Y-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.279, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 35.8, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-AX-A06B": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "95e6d327-9ab7-45de-9527-f5634b3995c3", "AGE": 72.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2058", "DAYS_TO_BIRTH": -26348.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 67.6595325, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 67.6595325, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 67.6595325, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 67.6595325, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A06B-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2743, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 220.0 }, "treatments": [] }, "TCGA-BG-A0MG": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9cde90c8-2be0-4328-a032-ff1dc19e66fd", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1477", "DAYS_TO_BIRTH": -26957.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.55837196, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.55837196, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 48.55837196, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.55837196, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0MG-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2676, "MSI_SENSOR_SCORE": 0.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.333333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 24.0 }, "treatments": [] }, "TCGA-D1-A17D": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7ddeddd1-b2ad-425f-94a2-9c476b959f2a", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "926", "DAYS_TO_BIRTH": -21441.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.44350199, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.44350199, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.44350199, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.44350199, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17D-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6777, "MSI_SENSOR_SCORE": 18.85, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 16.06666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 920.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 77, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2010.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 57, "STOP_DATE": 66.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A1GU": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5dd28537-d24f-4a6d-a454-6f64cf37e16a", "AGE": 66.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "378", "DAYS_TO_BIRTH": -24304.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 32.77772298, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.77772298, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.77772298, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.77772298, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GU-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9342, "MSI_SENSOR_SCORE": 22.78, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 40.13333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 94, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A1NZ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e49f545f-3268-4d25-b7a3-4da8e6ab2578", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "548", "DAYS_TO_BIRTH": -22027.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.01624092, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.01624092, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.01624092, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.01624092, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A1NZ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.898, "MSI_SENSOR_SCORE": 18.91, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 24.16666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BG-A0M3": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8bdd4e0e-5bec-43f2-b9fa-d6e94a72fe05", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1071", "DAYS_TO_BIRTH": -27183.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/1/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.21057304, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.21057304, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.21057304, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.21057304, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0M3-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.277, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 80, "STOP_DATE": 87.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0TI": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "df857bc6-fd6a-4713-bef9-6ee1301e5fb1", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1882", "DAYS_TO_BIRTH": -23705.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.87329454, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.87329454, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.87329454, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.87329454, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0TI-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3761, "MSI_SENSOR_SCORE": 0.9, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.8, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 125.0 }, "treatments": [] }, "TCGA-B5-A5OE": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "D5EE39E8-A1D2-4244-9C38-07D7C5C1BABA", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1063", "DAYS_TO_BIRTH": -24905.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.94756222, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.94756222, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.94756222, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A5OE-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3429, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.333333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 292.0 }, "treatments": [ { "START_DATE": 69, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 100, "STOP_DATE": 196.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Ixabepilone", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 69, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FI-A2D4": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "490AE247-EE67-48D4-94ED-93DF5B9BBEFE", "AGE": 44.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -16163.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 112.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 7.988953546, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 7.988953546, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.988953546, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2D4-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.814, "MSI_SENSOR_SCORE": 14.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.96666667, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 47, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 47, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "partial response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0LH": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7dce4215-01f6-43e9-9378-9e22c26c23a2", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22169.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 36.36124536, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 36.36124536, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 9.928658316, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.928658316, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LH-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.246, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 157.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1932.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 327, "STOP_DATE": 446.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "750", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 16560.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 82, "STOP_DATE": 197.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2730.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 324, "STOP_DATE": 446.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ixabepilone", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "30", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 330.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 92, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A0IS": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2e5cf721-90b1-4470-b430-f055a1297c7f", "AGE": 52.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1541", "DAYS_TO_BIRTH": -19173.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/17/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 132.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 61.08426209, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 61.08426209, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 14.72860571, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 14.72860571, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A0IS-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2846, "MSI_SENSOR_SCORE": 0.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.6, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 583, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 4.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 513, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Brivanib", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 3.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1065, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Other", "TREATMENT_SUBTYPE": "Investigational New Drug", "AGENT": "Tivozanib", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 5.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 13, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "adjuvant", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A0IZ": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "11285dc5-8742-477a-8692-af1b6e2c1434", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1333", "DAYS_TO_BIRTH": -19364.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 43.82417727, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 43.82417727, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 43.82417727, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 43.82417727, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A0IZ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5541, "MSI_SENSOR_SCORE": 9.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-A5-A2K2": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "840FF11F-F991-4E1B-861B-98D236D573D3", "AGE": 77.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "3595", "DAYS_TO_BIRTH": -28456.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/4/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 50.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 118.1904856, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 118.1904856, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 118.1904856, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 118.1904856, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A2K2-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2927, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.166666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 299.0 }, "treatments": [ { "START_DATE": 138, "STOP_DATE": 138.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "300", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 300.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 54, "STOP_DATE": 180.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "325", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1950.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 54, "STOP_DATE": 180.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 7.0, "PRESCRIBED_DOSE": "165", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1655.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FI-A2D2": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "46A1FDB9-548D-44D1-AB77-D51D44AC8198", "AGE": 66.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1215", "DAYS_TO_BIRTH": -24260.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 166.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 77.32518, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 77.32518, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 63.02396686, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 63.02396686, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2D2-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2878, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 165.0 }, "treatments": [ { "START_DATE": 87, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 87, "STOP_DATE": 191.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A2IN": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "FE79EBE1-CD0A-4CE2-A86D-637C28354ED9", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23275.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 100.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 31.13390538, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 31.13390538, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.449222474, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2IN-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7682, "MSI_SENSOR_SCORE": 11.9, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 17.33333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 288, "STOP_DATE": 605.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A1MY": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5d2f1a0f-a01b-48c2-b749-1ca710aa2bb4", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22805.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/17/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 67.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.86836309, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 11.86836309, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.94782523, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B5-A1MY-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3174, "MSI_SENSOR_SCORE": 0.61, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.633333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 271.0 }, "treatments": [ { "START_DATE": 106, "STOP_DATE": 218.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 106, "STOP_DATE": 218.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "645", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 133, "STOP_DATE": 164.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 32.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 214, "STOP_DATE": 228.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1200.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Radioisotope", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0VT": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "cc058b8c-df40-4f9e-88e3-3d1131b22b41", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1568", "DAYS_TO_BIRTH": -20602.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 144.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.55012, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.55012, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.55012, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.55012, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0VT-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2866, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 79, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 79, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A2AD": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "49adc60f-211b-4547-84f6-094257767409", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "609", "DAYS_TO_BIRTH": -23064.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.02169839, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.02169839, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.02169839, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.02169839, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A2AD-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": null, "MSI_SENSOR_SCORE": null, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 38.0 }, "treatments": [] }, "TCGA-A5-A0R7": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "02b25675-094d-4098-96da-51d121380fec", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "535", "DAYS_TO_BIRTH": -20250.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 136.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.58884834, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.58884834, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.58884834, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.58884834, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0R7-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2748, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.3, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 37.0 }, "treatments": [] }, "TCGA-A5-A1OH": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9BCE44A2-DCEE-4D1A-A522-C2BCB9A8E025", "AGE": 86.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1105", "DAYS_TO_BIRTH": -31451.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.328369, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.328369, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.328369, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.328369, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A1OH-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3161, "MSI_SENSOR_SCORE": 0.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.8, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 598.0 }, "treatments": [ { "START_DATE": 251, "STOP_DATE": 321.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 251, "STOP_DATE": 265.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A2HA": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9D84DFF8-6C19-4881-93C6-56C98A3049B5", "AGE": 35.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2475", "DAYS_TO_BIRTH": -13142.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 81.3689713, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 81.3689713, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 81.3689713, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 81.3689713, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2HA-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.3049, "MSI_SENSOR_SCORE": 35.7, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 50.6, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 6.0 }, "treatments": [] }, "TCGA-A5-A2K7": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "F42868C0-FF59-438B-90A7-489AEA678DE9", "AGE": 41.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1063", "DAYS_TO_BIRTH": -14980.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.94756222, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.94756222, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.94756222, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.94756222, "GENETIC_ANCESTRY_LABEL": "AMR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A2K7-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9748, "MSI_SENSOR_SCORE": 20.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 20.5, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 94, "STOP_DATE": 94.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 705.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 94, "STOP_DATE": 94.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 290.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 75, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-K6-A3WQ": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "D6303A05-F705-4413-8860-506A105D5B08", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "400", "DAYS_TO_BIRTH": -22092.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/26/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 99.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 14.03820232, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 14.03820232, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.53959957, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-K6-A3WQ-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "K6", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3158, "MSI_SENSOR_SCORE": 0.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "ABS - Lahey Clinic", "TBL_SCORE": 289.0 }, "treatments": [ { "START_DATE": 75, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 75, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 384, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 351, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 246, "STOP_DATE": 258.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A3S1": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3789AE3F-286B-42F0-A805-320AD69EA1DF", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "902", "DAYS_TO_BIRTH": -26031.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/9/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.65446954, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.65446954, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.65446954, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.65446954, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A3S1-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3135, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.033333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 281.0 }, "treatments": [ { "START_DATE": 51, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 51, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 120, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A7WK": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "DED408EE-053A-43ED-9BCF-1D15CD203051", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "560", "DAYS_TO_BIRTH": -26044.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/22/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 97.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.41075714, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.41075714, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 11.50672321, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.50672321, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A7WK-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3449, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.133333333, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 449.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 357, "STOP_DATE": 443.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 506, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3EK": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "14DB56EF-EC5E-4775-A229-5D83E58E027C", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "446", "DAYS_TO_BIRTH": -19609.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.66285301, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.66285301, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.66285301, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.66285301, "GENETIC_ANCESTRY_LABEL": "AMR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3EK-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4287, "MSI_SENSOR_SCORE": 3.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 192.3666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 126, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 126, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 84, "STOP_DATE": 81.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A2G7": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "32B5D0E4-A242-44D1-AC20-6E5CA2F35B71", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "1365", "DAYS_TO_BIRTH": -23913.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 133.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 58.94729921, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 58.94729921, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 58.94729921, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 58.94729921, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A2G7-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2867, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 171.0 }, "treatments": [] }, "TCGA-EO-A22X": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "10EB7DFA-D43D-479F-8C46-C0424207F958", "AGE": 36.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1752", "DAYS_TO_BIRTH": -13245.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 56.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 57.59936877, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 57.59936877, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 57.59936877, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 57.59936877, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A22X-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3086, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 317.6666667, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 47.0 }, "treatments": [] }, "TCGA-EY-A2OQ": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "029F0F1D-DD22-44D2-A623-CB9A33CB9438", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "885", "DAYS_TO_BIRTH": -22309.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.09557156, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.09557156, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.09557156, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.09557156, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A2OQ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3004, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 322.0 }, "treatments": [] }, "TCGA-A5-A0VP": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2db0fb62-64ce-457c-9e22-dd05ef59f684", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1288", "DAYS_TO_BIRTH": -27335.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 42.34474143, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 42.34474143, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 42.34474143, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 42.34474143, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0VP-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5739, "MSI_SENSOR_SCORE": 13.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 49.2, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 840, "STOP_DATE": 876.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0VQ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "23489245-48d7-4f19-8a42-e23b1181412b", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "485", "DAYS_TO_BIRTH": -22995.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.94503074, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.94503074, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.94503074, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.94503074, "GENETIC_ANCESTRY_LABEL": "AMR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0VQ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6689, "MSI_SENSOR_SCORE": 15.57, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.23333333, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 68, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 680.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 68, "STOP_DATE": 89.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1110.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 141, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0L8": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9aa8c2b4-db32-4899-bf0c-d578cb175e90", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25733.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 48.78850643, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 48.78850643, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 47.76933951, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 47.76933951, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0L8-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3118, "MSI_SENSOR_SCORE": 1.78, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.0, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 153.0 }, "treatments": [ { "START_DATE": 131, "STOP_DATE": 142.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 8.0, "RADIATION_DOSAGE": 1440.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 102, "STOP_DATE": 130.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 20.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1456, "STOP_DATE": 1467.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 9.0, "RADIATION_DOSAGE": 2693.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A1OF": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "286c112d-7b73-40a1-b23c-99911388fdef", "AGE": 47.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "973", "DAYS_TO_BIRTH": -17308.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 70.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.98869054, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.98869054, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.98869054, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.98869054, "GENETIC_ANCESTRY_LABEL": "AMR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A1OF-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4126, "MSI_SENSOR_SCORE": 1.9, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 352.4333333, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 8.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A103": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7427f9e8-1140-45fd-9613-78b72b13a7ba", "AGE": 87.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "669", "DAYS_TO_BIRTH": -31841.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.99427952, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.99427952, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.99427952, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.99427952, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A103-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4066, "MSI_SENSOR_SCORE": 3.98, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 229.5666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-BG-A0M6": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "002724fa-7051-49fa-9c58-4bcb7eba4ac6", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "241", "DAYS_TO_BIRTH": -26666.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/1/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 55.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 22.06003222, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.06003222, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.06003222, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.06003222, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0M6-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3034, "MSI_SENSOR_SCORE": 0.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 180.0 }, "treatments": [ { "START_DATE": 45, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "260", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1545.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 45, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "450", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2280.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 195, "STOP_DATE": 227.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 231, "STOP_DATE": 241.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1800.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A1CN": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d70b3c6e-04da-4abc-a832-a461e4cfcc94", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1143", "DAYS_TO_BIRTH": -19860.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 146.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.57767038, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.57767038, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 36.328369, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1CN-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3094, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 7.0 }, "treatments": [] }, "TCGA-D1-A16O": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8f508b78-cdc6-4a3d-b86e-520746d78653", "AGE": 44.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1023", "DAYS_TO_BIRTH": -16114.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 102.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.63250814, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.63250814, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.63250814, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.63250814, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16O-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2821, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-D1-A16N": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "dbbbddae-d711-40f5-bd10-863735885b1f", "AGE": 51.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "945", "DAYS_TO_BIRTH": -18787.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.06815268, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.06815268, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 31.06815268, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 31.06815268, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16N-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3686, "MSI_SENSOR_SCORE": 3.98, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.333333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 129.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 49.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 710.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 49, "STOP_DATE": 49.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 340.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 46, "STOP_DATE": 52.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0VV": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6164588a-d03a-46fc-82fb-a32cbaa54cac", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1553", "DAYS_TO_BIRTH": -19581.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 147.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.05697472, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.05697472, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.05697472, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.05697472, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0VV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2528, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-B5-A3FD": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "EEB327B4-B705-4161-BA94-647F0E14F5B4", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1007", "DAYS_TO_BIRTH": -25813.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/26/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 115.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 39.35299339, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.35299339, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 18.47650985, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A3FD-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2815, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 109.0 }, "treatments": [ { "START_DATE": 561, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": 11.0, "PRESCRIBED_DOSE": "1641", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 561, "STOP_DATE": 677.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 561, "STOP_DATE": 677.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "350", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A05Y": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "cbe0bd4a-02b7-43e7-b08e-2b0f13560eaf", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2684", "DAYS_TO_BIRTH": -20904.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 92.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 88.24012888, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 88.24012888, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 6.378012296, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.378012296, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A05Y-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5212, "MSI_SENSOR_SCORE": 7.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.166666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-D1-A2G0": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6F661F0D-F08B-486E-8BD7-4306E1593EB9", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "1484", "DAYS_TO_BIRTH": -25573.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.78850643, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.78850643, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.78850643, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A2G0-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.938, "MSI_SENSOR_SCORE": 23.71, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 27.36666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 8.0 }, "treatments": [] }, "TCGA-BG-A0MU": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a7329910-b1c7-4a18-b28e-8fad79121339", "AGE": 78.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "617", "DAYS_TO_BIRTH": -28621.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.28470921, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.28470921, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.28470921, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.28470921, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0MU-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2799, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 232, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": 120.0, "TOTAL_DOSE_UNITS": "mg/day", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 58, "STOP_DATE": 92.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 108, "STOP_DATE": 114.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 2.0, "RADIATION_DOSAGE": 500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0UT": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e2b1d0de-5221-44a1-8fad-9708a3cada14", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2212", "DAYS_TO_BIRTH": -22775.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 72.72249071, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 72.72249071, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 72.72249071, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 72.72249071, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0UT-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2888, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-EY-A1GC": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ebc25a41-becb-4395-ae33-483a304b07d8", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1647", "DAYS_TO_BIRTH": -22656.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 96.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 54.14735181, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 54.14735181, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 54.14735181, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 54.14735181, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GC-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2988, "MSI_SENSOR_SCORE": 0.71, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 288.0 }, "treatments": [] }, "TCGA-A5-A0VO": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0648f046-2206-4b97-9b6e-419c2e325b6d", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "364", "DAYS_TO_BIRTH": -23547.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/6/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 86.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 28.76680804, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.76680804, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.76680804, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.76680804, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0VO-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2792, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": null }, "treatments": [ { "START_DATE": 90, "STOP_DATE": 128.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A3GI": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E4787C7B-40E7-483C-98C0-38DA03E26B56", "AGE": 66.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "12", "DAYS_TO_BIRTH": -24388.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/7/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.394516225, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.394516225, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.394516225, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3GI-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2908, "MSI_SENSOR_SCORE": 1.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 269.0 }, "treatments": [] }, "TCGA-D1-A175": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f0b3ab10-43f8-48a8-b460-66ceaaf637db", "AGE": 48.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "202", "DAYS_TO_BIRTH": -17802.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 6.641023112, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.641023112, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 6.641023112, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.641023112, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A175-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.0047, "MSI_SENSOR_SCORE": 36.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2190.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 74, "STOP_DATE": 123.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "260", "PRESCRIBED_DOSE_UNITS": "mg/m2/day", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1200.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 52, "STOP_DATE": 56.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A3FT": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8B4CF993-1E16-4009-A37F-A629528B7D7E", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "6", "DAYS_TO_BIRTH": -23543.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.197258112, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.197258112, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.197258112, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3FT-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8254, "MSI_SENSOR_SCORE": 20.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 43.16666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-EO-A3B1": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2CF8DE9F-B305-4D98-BFD4-33377BF6138F", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "820", "DAYS_TO_BIRTH": -23162.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.95860867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.95860867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.95860867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.95860867, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A3B1-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2923, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 227.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 63, "STOP_DATE": 234.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 63, "STOP_DATE": 234.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 105, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4.5, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-SL-A6J9": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "C1F1DC90-2C67-4862-9E5F-078B861FFC6E", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "2", "DAYS_TO_BIRTH": -26701.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/12/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.065752704, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.065752704, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.065752704, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-SL-A6J9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "SL", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3503, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.633333333, "TISSUE_SOURCE_SITE": "St. Joseph's Hospital AZ", "TBL_SCORE": 190.0 }, "treatments": [] }, "TCGA-AX-A05Z": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "bf632368-8ce7-4b4b-8842-d1b1801e62ef", "AGE": 37.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2175", "DAYS_TO_BIRTH": -13529.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.50606569, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.50606569, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 71.50606569, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 71.50606569, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-AX-A05Z-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2617, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 246.4666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 152, "STOP_DATE": 152.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 61, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 61, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "adjuvent", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 61, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "adjuvent", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 61, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Pegfilgrastim", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "adjuvent", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 152, "STOP_DATE": 152.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "adjuvent", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FI-A2CY": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "B9AB4AB9-BA9C-4A01-9F61-55C82B924936", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2080", "DAYS_TO_BIRTH": -22098.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 100.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 68.38281224, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 68.38281224, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 68.38281224, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 68.38281224, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2CY-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2839, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 185.0 }, "treatments": [ { "START_DATE": 51, "STOP_DATE": 171.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 51, "STOP_DATE": 80.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 101, "STOP_DATE": 171.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0LN": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "60fcf50a-8598-475d-8dd0-6b3044661233", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "2510", "DAYS_TO_BIRTH": -20704.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 119.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 82.51964362, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 82.51964362, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 82.51964362, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 82.51964362, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LN-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2415, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BS-A0T9": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4eb95566-0e73-4260-853e-f7df650667a0", "AGE": 39.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -14253.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Native Hawaiian or Other Pacific Islander", "RADIATION_THERAPY": "No", "WEIGHT": 109.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 46.94743071, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 46.94743071, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 20.84360719, "GENETIC_ANCESTRY_LABEL": "EAS_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0T9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2737, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 15.0 }, "treatments": [ { "START_DATE": 950, "STOP_DATE": 979.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Fulvestrant", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": "250", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IM", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 500.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1072, "STOP_DATE": 1243.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "2000", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 3.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 8000.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 18, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 8.0, "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1280.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1309, "STOP_DATE": 1379.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 8.0, "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 5.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 640.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1072, "STOP_DATE": 1243.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 9.0, "PRESCRIBED_DOSE": "50", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 3.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 200.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1309, "STOP_DATE": 1379.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 8.0, "PRESCRIBED_DOSE": "167", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 5.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1336.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 18, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 8.0, "PRESCRIBED_DOSE": "45", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 360.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1156, "STOP_DATE": 1243.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "50", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 4.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 300.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1309, "STOP_DATE": 1379.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": 8.0, "PRESCRIBED_DOSE": "15", "PRESCRIBED_DOSE_UNITS": "mg/kg", "REGIMEN_NUMBER": 5.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 120.0, "TOTAL_DOSE_UNITS": "mg/kg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 18, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 8.0, "PRESCRIBED_DOSE": "50", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 400.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1163, "STOP_DATE": 1250.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": 9.0, "PRESCRIBED_DOSE": "1000", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 4.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 9000.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1013, "STOP_DATE": 1055.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5600.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A3DH": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7D22FF96-9249-46B3-9CFA-E40DC4ECEBD6", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "573", "DAYS_TO_BIRTH": -25935.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.83814972, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.83814972, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.83814972, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.83814972, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A3DH-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3135, "MSI_SENSOR_SCORE": 1.8, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.0, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 358.0 }, "treatments": [ { "START_DATE": 46, "STOP_DATE": 50.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 21.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BK-A13C": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ce73d0aa-bb3d-4aa3-8ed3-e9912cf25d38", "AGE": 47.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "760", "DAYS_TO_BIRTH": -17317.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/17/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.98602755, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.98602755, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.98602755, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.98602755, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-BK-A13C-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2743, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.933333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-D1-A2G5": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "016E515E-7F78-4997-9B97-3628464D9222", "AGE": 50.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "1455", "DAYS_TO_BIRTH": -18322.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 143.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 47.83509222, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 47.83509222, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 36.88726699, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 36.88726699, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A2G5-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4585, "MSI_SENSOR_SCORE": 1.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.233333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-D1-A101": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9da5ecd0-a287-4e67-84b6-af9077a98009", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "53", "DAYS_TO_BIRTH": -22078.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.742446658, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.742446658, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.742446658, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.742446658, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A101-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5438, "MSI_SENSOR_SCORE": 16.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.56666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BG-A3EW": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "A31554AF-D77A-4862-8AED-4581FB2BD877", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "344", "DAYS_TO_BIRTH": -22705.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 126.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.3094651, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.3094651, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.3094651, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.3094651, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A3EW-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7928, "MSI_SENSOR_SCORE": 16.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 15.06666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 85.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 87, "STOP_DATE": 94.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 2.0, "RADIATION_DOSAGE": 1000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A3AZ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "38BF8476-FDE7-423B-BBAA-15483207DE39", "AGE": 80.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "826", "DAYS_TO_BIRTH": -29234.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 78.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.15586679, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.15586679, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.15586679, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.15586679, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A3AZ-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6422, "MSI_SENSOR_SCORE": 16.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 33.53333333, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 21.0 }, "treatments": [] }, "TCGA-AX-A05T": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0119eab6-00e7-4346-aa52-cbbeeba3621d", "AGE": 82.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1010", "DAYS_TO_BIRTH": -30137.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.20511556, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.20511556, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.20511556, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.20511556, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A05T-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2436, "MSI_SENSOR_SCORE": 0.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-EY-A1GM": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1a094c2b-9fba-4bb1-929d-bb2cdf874bee", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "210", "DAYS_TO_BIRTH": -22010.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 32.71197028, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 32.71197028, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 26.00519446, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 26.00519446, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GM-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2797, "MSI_SENSOR_SCORE": 0.59, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 212.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 103.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 900.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 55, "STOP_DATE": 103.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1830.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11F": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3ea53b15-37f0-446e-a130-6bb2dee56865", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "5651", "DAYS_TO_BIRTH": -20171.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 185.7842654, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 185.7842654, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 52.93092678, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 52.93092678, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11F-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2879, "MSI_SENSOR_SCORE": 0.52, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 1749, "STOP_DATE": 3411.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1625, "STOP_DATE": 1661.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 27.0, "RADIATION_DOSAGE": 5400.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A0JX": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "586d7b3f-67a8-4a22-862f-cf50de3c1598", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1787", "DAYS_TO_BIRTH": -22834.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 113.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 58.7500411, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 58.7500411, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 58.7500411, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 58.7500411, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0JX-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2686, "MSI_SENSOR_SCORE": 0.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 17.0 }, "treatments": [] }, "TCGA-FI-A3PV": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "60E307DD-E11E-40BA-93C1-7E8A1F669F60", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24898.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": 105.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 41.0625637, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 41.0625637, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 41.0625637, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A3PV-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2839, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 333.0 }, "treatments": [] }, "TCGA-B5-A3FB": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0C1946A8-EE54-4B9B-8054-9A7BECE74D33", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2844", "DAYS_TO_BIRTH": -26779.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/23/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 115.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 93.5003452, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 93.5003452, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 93.5003452, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A3FB-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2756, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 141.0 }, "treatments": [] }, "TCGA-BK-A13B": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E71B3CE1-41E0-4CFC-9570-367B8C2124C1", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "966", "DAYS_TO_BIRTH": -21493.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 131.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 31.75855607, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 31.75855607, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 24.98602755, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 24.98602755, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-BK-A13B-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8641, "MSI_SENSOR_SCORE": 22.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.33333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 91, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 131, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 2.0, "RADIATION_DOSAGE": 1200.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A1GI": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "16bde24f-61b8-458d-aca3-df4806abbd1b", "AGE": 52.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "710", "DAYS_TO_BIRTH": -19117.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 69.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.34220995, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.34220995, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.34220995, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.34220995, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GI-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2889, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 150.9, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 80, "STOP_DATE": 94.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0LL": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d17668c4-5d66-4e16-8b70-b54616581aae", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "2554", "DAYS_TO_BIRTH": -20700.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 83.96620311, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 83.96620311, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 25.97231811, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 25.97231811, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LL-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2821, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 829, "STOP_DATE": 1133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen", "NUMBER_OF_CYCLES": 7.0, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 5880.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 829, "STOP_DATE": 1133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": 7.0, "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 24640.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 79, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3BI": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "525FB4FC-2167-4506-B4FA-FB896BF64CD0", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "575", "DAYS_TO_BIRTH": -24623.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 100.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.90390242, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.90390242, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.26287931, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3BI-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2936, "MSI_SENSOR_SCORE": 0.45, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 80.0 }, "treatments": [ { "START_DATE": 399, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 399, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A0ZU": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d74bc72e-8103-4aed-8958-5f40953d48eb", "AGE": 34.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "872", "DAYS_TO_BIRTH": -12458.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8382/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 94.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.66817898, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.66817898, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.66817898, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.66817898, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A0ZU-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2884, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 32, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2260.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 32, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 5410.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 173, "STOP_DATE": 208.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 5000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0LM": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "43e228ae-c890-444f-afbd-49385562e33a", "AGE": 33.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "825", "DAYS_TO_BIRTH": -12309.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 100.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.12299043, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.12299043, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.12299043, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.12299043, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LM-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3086, "MSI_SENSOR_SCORE": 3.61, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 442.3333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 117, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 350.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 114, "STOP_DATE": 149.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 23.0, "RADIATION_DOSAGE": 4140.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3IA": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8A0A58A0-5C12-4366-AF43-4FD25F8FF454", "AGE": 77.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "633", "DAYS_TO_BIRTH": -28470.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.81073084, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.81073084, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.81073084, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.81073084, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3IA-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3185, "MSI_SENSOR_SCORE": 0.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.7, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 501.0 }, "treatments": [] }, "TCGA-KP-A3W3": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0264C9C2-6B6A-485C-98F5-AED4F52ED0CA", "AGE": 72.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "794", "DAYS_TO_BIRTH": -26310.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 126.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.10382352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.10382352, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 21.7312687, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 21.7312687, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-KP-A3W3-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "KP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4075, "MSI_SENSOR_SCORE": 0.55, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "British Columbia Cancer Agency", "TBL_SCORE": 147.0 }, "treatments": [] }, "TCGA-AX-A3FW": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3052065A-B8B1-48D3-971D-9D605292249C", "AGE": 66.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "17", "DAYS_TO_BIRTH": -24419.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.558897985, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.558897985, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.558897985, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3FW-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3134, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 281.0 }, "treatments": [] }, "TCGA-AJ-A5DV": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "C7B3AC87-5260-4042-895A-279CD8CDA620", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "679", "DAYS_TO_BIRTH": -23892.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 147.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.32304304, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.32304304, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.32304304, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.32304304, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A5DV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3053, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-A5-A3LO": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2A2BC155-CA7C-48B2-BB77-CCFD6313710A", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "776", "DAYS_TO_BIRTH": -23401.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 103.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.51204918, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.51204918, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.51204918, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.51204918, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A3LO-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3011, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 8.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2106.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 71, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1050.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 111, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A1CC": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "bc02493a-0296-4329-939a-bf91a4d0c16a", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "788", "DAYS_TO_BIRTH": -23795.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 99.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.90656541, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.90656541, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.90656541, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1CC-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3195, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.633333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 62.0 }, "treatments": [ { "START_DATE": 210, "STOP_DATE": 267.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 210, "STOP_DATE": 267.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "adjuvent", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A3FS": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8C6B9B54-58EB-4D5F-B8A9-8007163DB457", "AGE": 82.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1", "DAYS_TO_BIRTH": -30102.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 98.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.230134464, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.230134464, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.230134464, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3FS-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.0475, "MSI_SENSOR_SCORE": 28.76, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 25.43333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 18.0 }, "treatments": [] }, "TCGA-B5-A1N2": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d79e692c-5053-4484-a180-01a094c5ff45", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "389", "DAYS_TO_BIRTH": -25612.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/22/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 114.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 31.36403985, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 31.36403985, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 26.43258704, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 26.43258704, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A1N2-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3409, "MSI_SENSOR_SCORE": 2.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.766666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 237.0 }, "treatments": [ { "START_DATE": 85, "STOP_DATE": 239.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "135", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 85, "STOP_DATE": 239.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 141, "STOP_DATE": 178.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A2CH": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0CC9A11F-1AC4-431D-8F94-52A3BC02B572", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -26966.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 19.3970477, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 19.3970477, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.99441102, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A2CH-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3164, "MSI_SENSOR_SCORE": 0.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 201.0 }, "treatments": [ { "START_DATE": 98, "STOP_DATE": 276.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 98, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 312, "STOP_DATE": 402.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 578, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 1.0, "RADIATION_DOSAGE": 800.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0MI": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "b8588e0f-aad6-4ded-845e-3cff67a48d8f", "AGE": 83.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -30334.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 101.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 23.47371536, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.47371536, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.47371536, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0MI-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2475, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BG-A18B": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "62ae3bb1-8102-4693-aee6-4d8d0d2bc515", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "470", "DAYS_TO_BIRTH": -19550.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 116.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.45188546, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.45188546, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.45188546, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.45188546, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A18B-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8185, "MSI_SENSOR_SCORE": 23.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 12.46666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-BS-A0VI": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3405c549-7da5-48ee-ba48-177a67bbcc5d", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2646", "DAYS_TO_BIRTH": -21198.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 91.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.9908275, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.9908275, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 86.9908275, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 86.9908275, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0VI-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5701, "MSI_SENSOR_SCORE": 7.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.33333333, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-BK-A6W4": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8E7792B3-2B6C-47AC-ACBE-3DA7462A8321", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "300", "DAYS_TO_BIRTH": -22766.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/5/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 107.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.862905612, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.862905612, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.862905612, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.862905612, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-BK-A6W4-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3301, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.8, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 97, "STOP_DATE": 119.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 3750.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0TJ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f74da4c6-4291-46d2-abd4-7d7f6ef03b00", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2068", "DAYS_TO_BIRTH": -21663.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 67.98829602, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 67.98829602, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 67.98829602, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 67.98829602, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0TJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9925, "MSI_SENSOR_SCORE": 32.67, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 23.46666667, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 130.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 29.0, "RADIATION_DOSAGE": 6100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Combination", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DI-A1C3": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3f305a1f-1020-4ebb-82ab-fd132bcaea02", "AGE": 38.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "739", "DAYS_TO_BIRTH": -13885.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 144.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.29562416, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.29562416, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.29562416, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.29562416, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DI-A1C3-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2916, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-AJ-A5DW": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "C0B684D1-B96C-4420-9285-172402B7B123", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "390", "DAYS_TO_BIRTH": -20711.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/12/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 109.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.8217773, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.8217773, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.8217773, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.8217773, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A5DW-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3003, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 107.0, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 7.0 }, "treatments": [] }, "TCGA-E6-A1M0": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e3dcde4e-5def-4b89-97b4-047b8288919b", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1793", "DAYS_TO_BIRTH": -20629.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 114.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 58.94729921, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 58.94729921, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 58.94729921, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 58.94729921, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E6-A1M0-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E6", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2895, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 115.8666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 43, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "350", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2100.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 43, "STOP_DATE": 148.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3882.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A2K5": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "CF77AFE9-3785-45D4-BA2A-61C9CB706225", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "752", "DAYS_TO_BIRTH": -28057.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/4/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 127.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.72301673, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.72301673, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.72301673, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.72301673, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A2K5-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2961, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 285.5, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 87, "STOP_DATE": 129.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FI-A3PX": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3E8E34C8-766A-4514-97F4-8000B5350AB9", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "2384", "DAYS_TO_BIRTH": -21063.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 78.37722326, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 78.37722326, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 78.37722326, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 78.37722326, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A3PX-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3305, "MSI_SENSOR_SCORE": 0.5, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.9, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 636.0 }, "treatments": [] }, "TCGA-BG-A0W1": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2d750c67-24a2-4b12-b4f2-dbd65f2f27f0", "AGE": 89.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1607", "DAYS_TO_BIRTH": -32750.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 56.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.83229773, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.83229773, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 52.83229773, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.83229773, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0W1-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3122, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-D1-A16B": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "bca1057a-1e96-404d-8a37-5a8dc1944ee7", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "1106", "DAYS_TO_BIRTH": -23450.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 86.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.36124536, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.36124536, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.36124536, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.36124536, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16B-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2725, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.6, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-EY-A212": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "37981e2c-4761-4f82-aaf2-4e6963a71603", "AGE": 83.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "110", "DAYS_TO_BIRTH": -30680.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8460/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.19166913, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 10.19166913, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 10.19166913, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A212-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3103, "MSI_SENSOR_SCORE": 0.53, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 691.0 }, "treatments": [] }, "TCGA-BG-A222": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "397b2672-d014-4b57-88dd-17e66ff8be4d", "AGE": 49.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "291", "DAYS_TO_BIRTH": -18220.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 132.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.567018444, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.567018444, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.567018444, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.567018444, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A222-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.1195, "MSI_SENSOR_SCORE": 25.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 143.4666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 7.0 }, "treatments": [] }, "TCGA-B5-A1MR": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "02af18ee-ab8e-4ac3-b22e-dec80c201058", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "6859", "DAYS_TO_BIRTH": -24017.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 225.4988986, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 225.4988986, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 225.4988986, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 225.4988986, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A1MR-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3618, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 244.3666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 21.0 }, "treatments": [] }, "TCGA-A5-A0GR": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "82c51af5-4ba2-48fe-b5e2-a0f1c9d68f34", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1120", "DAYS_TO_BIRTH": -25353.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.82151429, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.82151429, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.82151429, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.82151429, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GR-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2857, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 229.0 }, "treatments": [] }, "TCGA-AX-A2HD": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "A8DEF1A0-A136-47F4-9AD9-60EBCF9B726B", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1414", "DAYS_TO_BIRTH": -25499.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 51.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 46.48716179, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 46.48716179, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 46.48716179, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2HD-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9828, "MSI_SENSOR_SCORE": 25.8, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 263.8333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 13.0 }, "treatments": [] }, "TCGA-EO-A3KU": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "DB67A9CD-65BA-4D6F-A799-031B6B3DF599", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "677", "DAYS_TO_BIRTH": -25116.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.25729033, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.25729033, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.25729033, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.25729033, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-EO-A3KU-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3216, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.833333333, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 235.0 }, "treatments": [ { "START_DATE": 72, "STOP_DATE": 265.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 63, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 2, "STOP_DATE": 276.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 132, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 132, "STOP_DATE": 167.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A059": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4549bff6-6886-4102-a1de-02691b664c52", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1461", "DAYS_TO_BIRTH": -25311.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 99.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.03235033, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.03235033, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 48.03235033, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.03235033, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A059-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3351, "MSI_SENSOR_SCORE": 3.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 366.1666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 78, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A2H7": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "A1780432-860E-4BFF-9B66-A1E25C0076FE", "AGE": 87.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1020", "DAYS_TO_BIRTH": -32100.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 40.79955288, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 40.79955288, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 22.4874248, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 22.4874248, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2H7-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2908, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.6, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 22.0 }, "treatments": [] }, "TCGA-B5-A0K3": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "79ecc142-8f6e-4260-a7ce-c8e2a6212c35", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "700", "DAYS_TO_BIRTH": -22664.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 27.28737219, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 27.28737219, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 8.416346122, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0K3-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2639, "MSI_SENSOR_SCORE": 0.55, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.833333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 397.0 }, "treatments": [ { "START_DATE": 630, "STOP_DATE": 726.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "410", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 3.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 756, "STOP_DATE": 798.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Topotecan", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": "3.8", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 4.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 301, "STOP_DATE": 392.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "650", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 301, "STOP_DATE": 392.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "330", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 546, "STOP_DATE": 602.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "70", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A0ZS": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "80105773-372e-4552-a10b-5df188b15b16", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "148", "DAYS_TO_BIRTH": -19821.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 4.865700102, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 4.865700102, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 4.865700102, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 4.865700102, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A0ZS-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7448, "MSI_SENSOR_SCORE": 28.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.1, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 47, "STOP_DATE": 54.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A167": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3d215e20-9eea-47e0-849e-cff1fee5634d", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "478", "DAYS_TO_BIRTH": -25575.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.71489628, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.71489628, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.71489628, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.71489628, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A167-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9382, "MSI_SENSOR_SCORE": 24.6, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 52.06666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 138, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A1E4": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0b2eb188-dd23-4dbf-91bb-02e3c81a69bc", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1555", "DAYS_TO_BIRTH": -19814.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 54.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.12272742, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.12272742, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 5.194463622, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1E4-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.301, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 186, "STOP_DATE": 344.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Zoledronic Acid", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 12.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 204, "STOP_DATE": 309.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2860.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 204, "STOP_DATE": 309.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1650.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 96, "STOP_DATE": 124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1800.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11L": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "07b24a23-3d9f-4591-800f-8738cc232f9a", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1396", "DAYS_TO_BIRTH": -26120.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 92.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 73.64302857, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.64302857, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 4.306802117, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 4.306802117, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11L-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3009, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.733333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-AJ-A6NU": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "41E14A71-95DF-46D3-A357-A227A00029CF", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "632", "DAYS_TO_BIRTH": -23498.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/30/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 167.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.77785449, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.77785449, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.77785449, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.77785449, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A6NU-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3416, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 179.0 }, "treatments": [] }, "TCGA-BG-A2L7": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "214A09BB-CE52-4055-B036-065E8CB7AC7D", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "612", "DAYS_TO_BIRTH": -25091.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/18/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.12032745, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.12032745, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.12032745, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.12032745, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A2L7-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8115, "MSI_SENSOR_SCORE": 17.46, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 39.76666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 85, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 189, "STOP_DATE": 202.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 21.1, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-4E-A92E": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "B43DE98D-4BB1-41A1-91F2-CE4E7EA4D0CA", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "13", "DAYS_TO_BIRTH": -19818.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/20/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.427392577, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.427392577, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.427392577, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.427392577, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-4E-A92E-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "4E", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3396, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.9, "TISSUE_SOURCE_SITE": "Molecular Response", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-H5-A2HR": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "FDB395E7-FF30-400D-861E-0CF2462EE390", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "39", "DAYS_TO_BIRTH": -25986.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.742446658, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.742446658, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.742446658, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-H5-A2HR-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "H5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2896, "MSI_SENSOR_SCORE": 0.51, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "Medical College of Georgia", "TBL_SCORE": 442.0 }, "treatments": [] }, "TCGA-A5-A0GU": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "adc22472-e31d-419f-aeae-cb01b9423343", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "860", "DAYS_TO_BIRTH": -21192.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.27366275, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.27366275, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.27366275, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.27366275, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GU-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.286, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 29.0 }, "treatments": [] }, "TCGA-AJ-A3BF": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "40287CDC-19DD-4370-A6A0-F324960E1148", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "551", "DAYS_TO_BIRTH": -23906.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8460/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 113.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.11486997, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.11486997, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 12.62451918, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.62451918, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3BF-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3014, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.866666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 281.0 }, "treatments": [ { "START_DATE": 75, "STOP_DATE": 251.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 75, "STOP_DATE": 251.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 411, "STOP_DATE": 457.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 5940.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 136, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 517, "STOP_DATE": 551.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 5500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A3FH": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "139E2C5A-CC0C-43A2-B30E-B8AC17C0B5F2", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "841", "DAYS_TO_BIRTH": -27221.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/23/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.64901207, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.64901207, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.64901207, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.64901207, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A3FH-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2786, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 76.0 }, "treatments": [] }, "TCGA-B5-A1MV": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0f36c3a2-0ba5-4c43-a3f0-78d125e5d0ac", "AGE": 84.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1565", "DAYS_TO_BIRTH": -30926.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.45149094, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.45149094, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.45149094, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.45149094, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A1MV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3134, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-KP-A3W0": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "C9EBAEFF-6A27-4A6C-A34C-5337A3508A52", "AGE": 72.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "404", "DAYS_TO_BIRTH": -26378.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 94.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.28204622, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.28204622, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.28204622, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.28204622, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-KP-A3W0-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "KP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2945, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "British Columbia Cancer Agency", "TBL_SCORE": 119.0 }, "treatments": [] }, "TCGA-AJ-A3OK": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "12DF24C6-1229-4777-AD90-7DD66259B65F", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "485", "DAYS_TO_BIRTH": -26851.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "4/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.94503074, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.94503074, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.94503074, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.94503074, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3OK-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4056, "MSI_SENSOR_SCORE": 1.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.96666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 71, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 71, "STOP_DATE": 71.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 158, "STOP_DATE": 177.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 7000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A8CT": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6C2232B2-80CE-4156-A0B4-FFA411B0963E", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "82", "DAYS_TO_BIRTH": -21515.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/27/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": 115.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.695860867, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.695860867, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.695860867, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.695860867, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A8CT-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.503, "MSI_SENSOR_SCORE": 5.44, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.2, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-AP-A1DK": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "51de7e94-e2fa-420b-9aa2-3637d17fc6ea", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "2767", "DAYS_TO_BIRTH": -19509.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 56.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 90.9688661, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 90.9688661, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 90.9688661, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 90.9688661, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1DK-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5415, "MSI_SENSOR_SCORE": 4.49, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 346.5333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 92, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1800.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A16D": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5693302a-4548-4c0b-8725-0cb7c67bc4f8", "AGE": 49.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "1141", "DAYS_TO_BIRTH": -17933.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 151.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.51191768, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.51191768, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.51191768, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.51191768, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16D-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2708, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 62, "STOP_DATE": 232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "50", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2150.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 62, "STOP_DATE": 232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "2", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 10030.0, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 96, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A23O": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "70b4b353-10d4-49d0-bcc1-855616d8c8cc", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "60", "DAYS_TO_BIRTH": -25433.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.25742184, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.25742184, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.25742184, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A23O-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8244, "MSI_SENSOR_SCORE": 15.75, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 28.76666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-EY-A4KR": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "DF27B584-FA45-4A8F-BD12-A018CC63DCA1", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "196", "DAYS_TO_BIRTH": -20669.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/17/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 114.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.37521781, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 11.37521781, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.37521781, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A4KR-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2999, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.433333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 351.0 }, "treatments": [ { "START_DATE": 46, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 46, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 112, "STOP_DATE": 117.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 4.0, "RADIATION_DOSAGE": 720.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 238, "STOP_DATE": 278.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 27.0, "RADIATION_DOSAGE": 4860.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FI-A2D5": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "DCFBE781-A92A-45B5-B80A-E3BB3BDC0D9A", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -20666.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 92.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 13.84094421, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 13.84094421, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.205378571, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2D5-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3854, "MSI_SENSOR_SCORE": 0.82, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 465.9666667, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 21.0 }, "treatments": [ { "START_DATE": 133, "STOP_DATE": 245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 133, "STOP_DATE": 245.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 283, "STOP_DATE": 363.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 30.0, "RADIATION_DOSAGE": 60.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A3QX": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8BB89C0F-0F04-485E-8E08-801042DFCBA9", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "421", "DAYS_TO_BIRTH": -23663.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 32.51471217, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 32.51471217, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 29.45721143, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A3QX-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3143, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 246.0 }, "treatments": [ { "START_DATE": 66, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 66, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11J": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "027b2a29-2fad-4ca8-a7cd-eb913d0205f8", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1656", "DAYS_TO_BIRTH": -23485.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 134.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 54.44323898, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 54.44323898, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 54.44323898, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 54.44323898, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11J-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7092, "MSI_SENSOR_SCORE": 23.51, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.6, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-B5-A0JN": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "b60f22ac-a659-4f33-b01d-820e86a9a5c9", "AGE": 84.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2445", "DAYS_TO_BIRTH": -30933.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "Yes", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 80.38268074, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 80.38268074, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 80.38268074, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0JN-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3115, "MSI_SENSOR_SCORE": 0.59, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.7, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 396.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "275", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 48, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A1GE": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a28beb70-d309-45b8-a2ba-40558f3c8f4f", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "741", "DAYS_TO_BIRTH": -24667.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 103.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.36137686, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.36137686, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.36137686, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.36137686, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GE-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2908, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BG-A18A": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "feb3e930-3638-44b4-ac0f-a5dcb01fed76", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "426", "DAYS_TO_BIRTH": -27086.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.00532597, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.00532597, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.00532597, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.00532597, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A18A-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2765, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-D1-A17U": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6397c4a1-0a29-4c2c-b8cb-ce73af93dd0b", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "697", "DAYS_TO_BIRTH": -19544.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.91481737, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.91481737, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.91481737, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.91481737, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17U-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.792, "MSI_SENSOR_SCORE": 27.42, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.13333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 11.0 }, "treatments": [ { "START_DATE": 167, "STOP_DATE": 287.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2610.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 167, "STOP_DATE": 287.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "135", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1650.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 101, "STOP_DATE": 137.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 5500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-QS-A5YQ": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "03381D49-E25F-4376-8E36-F47063A7D3FB", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "759", "DAYS_TO_BIRTH": -20425.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/14/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.9531512, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.9531512, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.9531512, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.9531512, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-QS-A5YQ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "QS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.348, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 31.2, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": 93.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 128, "STOP_DATE": 198.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 128, "STOP_DATE": 198.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 65, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 45.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A06H": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e5d74e47-b63f-410a-8b7a-c9aacc9aa337", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "833", "DAYS_TO_BIRTH": -22270.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/17/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "American Indian or Alaska Native", "RADIATION_THERAPY": "No", "WEIGHT": 98.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.38600125, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.38600125, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.38600125, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.38600125, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A06H-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6159, "MSI_SENSOR_SCORE": 23.79, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.73333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 7.0, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2917.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 64, "STOP_DATE": 190.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 7.0, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2263.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11X": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f70a64a8-3faa-468a-a6f3-4815eb01e5a3", "AGE": 66.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "596", "DAYS_TO_BIRTH": -24217.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8020/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.59430582, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.59430582, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 13.05191176, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11X-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2725, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.0, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": null }, "treatments": [ { "START_DATE": 86, "STOP_DATE": 258.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Temozolomide", "NUMBER_OF_CYCLES": 8.0, "PRESCRIBED_DOSE": "25", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 65, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 65, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 412, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 8.0, "PRESCRIBED_DOSE": "101", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-QS-A5YR": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6696CF88-3C43-482C-AABB-F1EA5CF565AA", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "719", "DAYS_TO_BIRTH": -22372.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/13/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 100.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.63809712, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.63809712, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.63809712, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-QS-A5YR-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "QS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5106, "MSI_SENSOR_SCORE": 3.89, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.233333333, "TISSUE_SOURCE_SITE": "Candler", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-B5-A1MZ": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "838fcc2b-48b4-49dd-b8fc-ff27bbd16b17", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1598", "DAYS_TO_BIRTH": -19955.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/22/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 114.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.53641056, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.53641056, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 20.1532038, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 20.1532038, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A1MZ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2827, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-EO-A1Y7": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "71ed2681-79bb-4ffb-985c-6d3cf18e9168", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1495", "DAYS_TO_BIRTH": -24085.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 49.1501463, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 49.1501463, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 28.9311898, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A1Y7-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3284, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 350.0 }, "treatments": [ { "START_DATE": 911, "STOP_DATE": 1031.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Portec3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "radiation alone", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 117, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 27.0, "RADIATION_DOSAGE": 48.6, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3NE": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1DCF33E9-4C9B-4B2B-914E-15E6BE5DCD07", "AGE": 46.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "628", "DAYS_TO_BIRTH": -16957.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/17/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.64634908, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.64634908, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.64634908, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.64634908, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3NE-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.555, "MSI_SENSOR_SCORE": 8.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-AX-A3FV": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "A033FBEA-7CD0-4E65-94C4-B54F2F80B895", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "-6", "DAYS_TO_BIRTH": -22752.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 113.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.0, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.0, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.0, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3FV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3357, "MSI_SENSOR_SCORE": 2.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.733333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 237.0 }, "treatments": [] }, "TCGA-E6-A1LZ": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9205c164-7975-421a-90c3-edfe8def595c", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2406", "DAYS_TO_BIRTH": -28054.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 79.10050301, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 79.10050301, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 79.10050301, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 79.10050301, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-E6-A1LZ-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E6", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3134, "MSI_SENSOR_SCORE": 0.43, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.966666667, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 194.0 }, "treatments": [ { "START_DATE": 57, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "292", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1751.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 57, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "467", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2735.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 34, "STOP_DATE": 48.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0G2": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4abbd258-0f0c-4428-901d-625d47ad363a", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "4549", "DAYS_TO_BIRTH": -20953.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/16/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 149.5545254, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 149.5545254, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 149.5545254, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 149.5545254, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0G2-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4003, "MSI_SENSOR_SCORE": 8.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 861.8666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 45.0 }, "treatments": [ { "START_DATE": 29, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 39.0, "RADIATION_DOSAGE": 6000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3NC": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "C8FB94DD-C535-48F4-9419-AAC2BF47BBB4", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1125", "DAYS_TO_BIRTH": -23353.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "4/17/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 110.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.98589605, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.98589605, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.98589605, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.98589605, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3NC-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2928, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 25.0 }, "treatments": [] }, "TCGA-EY-A210": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ea1c693d-490d-4816-b6e3-d12946ad7cc1", "AGE": 82.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "383", "DAYS_TO_BIRTH": -30095.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "7/6/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.59164283, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.59164283, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.59164283, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.59164283, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-EY-A210-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2829, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 101.0 }, "treatments": [] }, "TCGA-AX-A2H5": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "C88E3901-F3EE-436A-BA80-143C8EAB7D69", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2167", "DAYS_TO_BIRTH": -24757.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.24305487, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.24305487, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 71.24305487, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 71.24305487, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2H5-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3194, "MSI_SENSOR_SCORE": 1.63, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.6, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 363.0 }, "treatments": [ { "START_DATE": 87, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 87, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0GG": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a8614c49-c7f1-4de9-bd2f-4764b094d604", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "3762", "DAYS_TO_BIRTH": -27809.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 123.6808364, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 123.6808364, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 123.6808364, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 123.6808364, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GG-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4172, "MSI_SENSOR_SCORE": 7.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 8.0 }, "treatments": [ { "START_DATE": 149, "STOP_DATE": 163.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-PG-A5BC": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "22669A01-21D3-404C-AC19-CF0A6C03BB1D", "AGE": 72.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "707", "DAYS_TO_BIRTH": -26436.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.24358089, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.24358089, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.24358089, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.24358089, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-PG-A5BC-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3104, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Montefiore Medical Center", "TBL_SCORE": 195.0 }, "treatments": [] }, "TCGA-EY-A2OO": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "068016E2-7829-493C-B8BE-D3B85BEAAB13", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1392", "DAYS_TO_BIRTH": -20797.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 45.76388204, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 45.76388204, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 45.76388204, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 45.76388204, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A2OO-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3071, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 54, "STOP_DATE": 165.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 54, "STOP_DATE": 165.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 96, "STOP_DATE": 116.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3BH": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "A7D07151-5FC8-4C2A-A1CD-E7C7A2A9A7A7", "AGE": null, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "[Completed]", "DAYS_TO_BIRTH": null, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": null, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": null, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": null, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": null, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3BH-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.0149, "MSI_SENSOR_SCORE": 28.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 90.0, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-D1-A0ZQ": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "38243a33-073a-479b-8cf6-c8847aeb5a48", "AGE": 90.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "260", "DAYS_TO_BIRTH": -32873.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 69.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 8.54785153, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 8.54785153, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 8.54785153, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 8.54785153, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A0ZQ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2599, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 73.0 }, "treatments": [] }, "TCGA-D1-A16E": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e70465f6-1922-4eb7-b646-8b01ad3ce77b", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "1119", "DAYS_TO_BIRTH": -26859.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.78863793, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.78863793, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.78863793, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.78863793, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16E-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2678, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-BS-A0TC": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7b7d2d2b-abe6-4f32-add0-3715096995d1", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2602", "DAYS_TO_BIRTH": -25560.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.3", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 85.54426801, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 85.54426801, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 85.54426801, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 85.54426801, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0TC-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2784, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 43.73333333, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-BK-A26L": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ab7adf74-6e87-4117-9742-54e323348e06", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "734", "DAYS_TO_BIRTH": -26002.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.1312424, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.1312424, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.1312424, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.1312424, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BK-A26L-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3083, "MSI_SENSOR_SCORE": 0.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.466666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 168.3 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 252.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 12.0, "PRESCRIBED_DOSE": "107-250", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1716.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 70, "STOP_DATE": 252.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "668-697", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 4153.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 151, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 186, "STOP_DATE": 192.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 2.0, "RADIATION_DOSAGE": 1200.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A0JY": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "61935424-44d0-4211-81c1-c925e436eac5", "AGE": 50.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2107", "DAYS_TO_BIRTH": -18475.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/4/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8020/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 67.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 69.27047375, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 69.27047375, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 69.27047375, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 69.27047375, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0JY-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3015, "MSI_SENSOR_SCORE": 0.87, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 325.1333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 105, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "50", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 105, "STOP_DATE": 205.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "45", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11R": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f04befed-6c81-4676-8715-b8c6a33cb9d1", "AGE": 51.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2349", "DAYS_TO_BIRTH": -18878.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 77.22655094, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 77.22655094, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 77.22655094, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 77.22655094, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11R-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2964, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 19.96666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 10.0 }, "treatments": [ { "START_DATE": 116, "STOP_DATE": 214.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "590", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 116, "STOP_DATE": 214.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "270", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 126, "STOP_DATE": 133.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-PG-A917": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "B1B9173C-B370-4FE5-A263-C807E8A9709C", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "212", "DAYS_TO_BIRTH": -27104.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 6.969786633, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 6.969786633, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 6.969786633, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 6.969786633, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-PG-A917-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.809, "MSI_SENSOR_SCORE": 22.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 24.26666667, "TISSUE_SOURCE_SITE": "Montefiore Medical Center", "TBL_SCORE": 25.0 }, "treatments": [] }, "TCGA-AP-A1DP": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a93c47a9-65b5-4785-af4f-a2078db4514e", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -25601.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 35.53933656, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 35.53933656, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 27.32024855, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 27.32024855, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1DP-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8032, "MSI_SENSOR_SCORE": 20.7, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 15.0, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 903, "STOP_DATE": 987.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2675.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 903, "STOP_DATE": 987.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1340.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 125, "STOP_DATE": 153.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1800.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BK-A6W3": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "119B1761-A5B4-42B6-9971-ECE11FB0E0F6", "AGE": 34.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "305", "DAYS_TO_BIRTH": -12590.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/29/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.02728737, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.02728737, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.02728737, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.02728737, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-BK-A6W3-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3435, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 131.8666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-A5-AB3J": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8A67ED86-156F-4B45-B460-000FE33DA26B", "AGE": 52.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "512", "DAYS_TO_BIRTH": -19020.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/8/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.83269224, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.83269224, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.83269224, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.83269224, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A5-AB3J-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.328, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 63, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 85, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A1GJ": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "13b97e99-f6b7-4253-b7e1-230cce2d8747", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "727", "DAYS_TO_BIRTH": -26715.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.90110793, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.90110793, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.90110793, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.90110793, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2833, "MSI_SENSOR_SCORE": 0.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 233.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A3GB": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "AA3AD7C0-37CF-4337-945E-CEFEEE801BBB", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "440", "DAYS_TO_BIRTH": -26724.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/7/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.4655949, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.4655949, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.4655949, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3GB-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3008, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.666666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 41, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin + Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A16R": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "40f43483-b504-4ea7-ad24-40682b10caac", "AGE": 39.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "21", "DAYS_TO_BIRTH": -14465.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 105.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.690403393, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.690403393, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 0.690403393, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.690403393, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16R-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2517, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 378.0 }, "treatments": [] }, "TCGA-B5-A5OD": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3E240DC0-80B7-41EA-81B3-33ECE2753C2B", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1038", "DAYS_TO_BIRTH": -24775.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.12565342, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.12565342, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.12565342, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B5-A5OD-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3578, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 339.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 241.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 63, "STOP_DATE": 241.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 133, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FI-A2EY": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "787C3E2F-A708-4985-A5B1-B2383C7BFC52", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -23042.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 96.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 28.9311898, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.9311898, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.9311898, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 18.96965513, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2EY-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3239, "MSI_SENSOR_SCORE": 1.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.266666667, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 270.0 }, "treatments": [ { "START_DATE": 27, "STOP_DATE": 172.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 27, "STOP_DATE": 172.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0GE": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a587e62e-430e-4f1b-82b7-6fbe856fdaf1", "AGE": 38.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "3205", "DAYS_TO_BIRTH": -14170.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 57.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 105.3687083, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 105.3687083, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 105.3687083, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 105.3687083, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GE-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2535, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 69.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A0K9": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4485cc98-5d58-4eb4-8325-7d1a617b6461", "AGE": 88.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "335", "DAYS_TO_BIRTH": -32289.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/20/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 13.44642798, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.44642798, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.44642798, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.44642798, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0K9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7746, "MSI_SENSOR_SCORE": 22.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 25.6, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 8.0 }, "treatments": [ { "START_DATE": 68, "STOP_DATE": 68.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A17T": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "efa4c675-e35e-4f48-8d12-a40f30b63ddb", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "71", "DAYS_TO_BIRTH": -24652.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.334220995, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.334220995, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.334220995, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.334220995, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17T-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2691, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.233333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-AJ-A3OL": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7F91A0C5-D639-48EA-B3F7-B6F385E047ED", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "57", "DAYS_TO_BIRTH": -20115.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 14.76148207, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 14.76148207, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 13.93957327, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 13.93957327, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3OL-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7708, "MSI_SENSOR_SCORE": 15.72, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.933333333, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 96, "STOP_DATE": 186.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 96, "STOP_DATE": 186.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A3F9": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "21941181-8ED5-4211-867D-516AD09FBE06", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "4155", "DAYS_TO_BIRTH": -20523.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 155.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 136.6012427, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 136.6012427, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 136.6012427, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A3F9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2781, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.966666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 25.0 }, "treatments": [] }, "TCGA-EO-A22T": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "63170B0E-78CF-45D9-AF9D-CE986AC66991", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "2035", "DAYS_TO_BIRTH": -20608.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 53.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.9033764, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.9033764, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 66.9033764, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.9033764, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-EO-A22T-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7835, "MSI_SENSOR_SCORE": 17.64, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 33.23333333, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 66, "STOP_DATE": 102.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A3AY": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0878E44D-BDC8-4D5F-9BF4-31101F14F797", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1158", "DAYS_TO_BIRTH": -21291.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.07081566, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.07081566, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 38.23519742, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 38.23519742, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A3AY-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2784, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 113.9, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-D1-A1NU": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e56491af-718f-4ca1-b3cd-0e5b3154697b", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "402", "DAYS_TO_BIRTH": -27272.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.21629352, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.21629352, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.21629352, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.21629352, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A1NU-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3328, "MSI_SENSOR_SCORE": 0.56, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.633333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 193.0 }, "treatments": [ { "START_DATE": 51, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1320.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 51, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1020.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 35, "STOP_DATE": 50.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A22Y": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E6183A43-24B9-4FE1-95C3-4CFF67E6C1ED", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1567", "DAYS_TO_BIRTH": -25127.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.51724365, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.51724365, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.51724365, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.51724365, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A22Y-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.306, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.633333333, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-B5-A11M": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "fd370e9d-2719-45e0-b8f1-048ed1ee602f", "AGE": 43.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1362", "DAYS_TO_BIRTH": -16063.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 139.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 44.77759148, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 44.77759148, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 44.77759148, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 44.77759148, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11M-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2609, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": null }, "treatments": [] }, "TCGA-AP-A05H": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "fe5f4822-37a3-4f9e-8d33-8b9f36bf6895", "AGE": 75.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1385", "DAYS_TO_BIRTH": -27744.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 89.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 45.53374758, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 45.53374758, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 45.53374758, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 45.53374758, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A05H-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3134, "MSI_SENSOR_SCORE": 2.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 374.0 }, "treatments": [ { "START_DATE": 65, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "135", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1500.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 65, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2340.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 71, "STOP_DATE": 99.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1800.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A3G6": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E31DB89C-15AC-45A4-9788-AFB339B0F3BC", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "8", "DAYS_TO_BIRTH": -24681.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.263010816, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.263010816, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.263010816, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3G6-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3125, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.833333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 98.0 }, "treatments": [] }, "TCGA-D1-A15Z": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "c5df9142-27f6-4d97-933e-c79ea9199362", "AGE": 72.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -26638.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 125.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 1.906828418, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.906828418, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.906828418, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.906828418, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A15Z-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2623, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-D1-A1NW": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d7258a64-3ea0-40fc-b3f4-b581a1725fff", "AGE": 72.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "22", "DAYS_TO_BIRTH": -26556.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 98.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.723279745, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.723279745, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.723279745, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A1NW-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3416, "MSI_SENSOR_SCORE": 0.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 176.0 }, "treatments": [] }, "TCGA-D1-A174": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "fc7315b0-9f48-4206-b197-2268c0518eb4", "AGE": 51.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "594", "DAYS_TO_BIRTH": -18702.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.52855311, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.52855311, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.52855311, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.52855311, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A174-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9107, "MSI_SENSOR_SCORE": 35.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 26.86666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 55.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A0K2": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a8079ea5-c37b-4f77-aca0-b043bf420675", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2209", "DAYS_TO_BIRTH": -20080.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 72.62386166, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 72.62386166, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 72.62386166, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 72.62386166, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0K2-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.522, "MSI_SENSOR_SCORE": 10.65, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.0, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 431.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A1CJ": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "abaf757b-f79f-40bd-96e3-e2c0f63061f0", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2233", "DAYS_TO_BIRTH": -21655.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 115.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 73.41289411, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.41289411, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 73.41289411, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1CJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2804, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 97, "STOP_DATE": 110.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DF-A2KY": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5BF97D66-CDC6-47D0-AC74-5C6280B31072", "AGE": 49.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "332", "DAYS_TO_BIRTH": -18086.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/20/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.91494888, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.91494888, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.91494888, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-DF-A2KY-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DF", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8855, "MSI_SENSOR_SCORE": 26.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research", "TBL_SCORE": 18.0 }, "treatments": [ { "START_DATE": 79, "STOP_DATE": 79.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 79, "STOP_DATE": 79.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-SJ-A6ZI": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3C2A6E30-A507-49F6-8B1F-36EB3AA41E60", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "631", "DAYS_TO_BIRTH": -23653.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/11/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.74497814, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.74497814, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.74497814, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.74497814, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-SJ-A6ZI-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "SJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6138, "MSI_SENSOR_SCORE": 14.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 43.93333333, "TISSUE_SOURCE_SITE": "Albert Einstein Medical Center", "TBL_SCORE": 12.0 }, "treatments": [ { "START_DATE": 86, "STOP_DATE": 86.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 21.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A2OM": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2B60EF45-336C-42E0-AA3F-577069310D1F", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "694", "DAYS_TO_BIRTH": -20398.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 110.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.81618832, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.81618832, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.81618832, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.81618832, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A2OM-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9415, "MSI_SENSOR_SCORE": 21.96, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.03333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 123, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 123, "STOP_DATE": 169.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 106, "STOP_DATE": 116.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A1CF": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "20dcf91a-0529-4e96-99a2-362a41fbe4a4", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2337", "DAYS_TO_BIRTH": -25300.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 76.83203472, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 76.83203472, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 28.76680804, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1CF-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2825, "MSI_SENSOR_SCORE": 0.92, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.1, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 133.0 }, "treatments": [ { "START_DATE": 1037, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Tamoxifen + Megestrol", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1799, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 2052, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 3.0, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1588, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0M7": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1d9c2113-ddcb-4440-89c3-cd21cee6d401", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1937", "DAYS_TO_BIRTH": -22096.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/1/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 102.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 63.6814939, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 63.6814939, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 63.6814939, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 63.6814939, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0M7-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2483, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 132, "STOP_DATE": 132.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "150", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 150.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 65, "STOP_DATE": 155.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "868", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 65, "STOP_DATE": 65.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "350", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 350.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 70, "STOP_DATE": 111.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 218, "STOP_DATE": 223.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 2.0, "RADIATION_DOSAGE": 1000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 182, "STOP_DATE": 216.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0GB": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2f4458b6-3caf-4e33-890e-a04722badd1b", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "997", "DAYS_TO_BIRTH": -23883.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 122.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.77772298, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.77772298, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.77772298, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.77772298, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GB-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.0919, "MSI_SENSOR_SCORE": 36.5, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 22.56666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 8.0 }, "treatments": [ { "START_DATE": 101, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-E6-A1LX": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "435b57e7-5cd4-486a-b3d4-ccb1ef160d52", "AGE": 40.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "711", "DAYS_TO_BIRTH": -14731.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.3750863, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.3750863, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.3750863, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.3750863, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-E6-A1LX-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E6", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3376, "MSI_SENSOR_SCORE": 0.41, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 426.1, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 35, "STOP_DATE": 49.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-QF-A5YS": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "DF15901C-2508-42C9-BF06-026EFD89E51F", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "689", "DAYS_TO_BIRTH": -20841.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/25/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.65180656, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.65180656, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.65180656, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.65180656, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-QF-A5YS-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "QF", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.323, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 52.36666667, "TISSUE_SOURCE_SITE": "BLN - Baylor", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 109, "STOP_DATE": 158.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 109, "STOP_DATE": 158.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 172, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 220, "STOP_DATE": 227.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1800.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A2IO": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8A235D4D-5EE1-4D6B-839E-E71CADCD8C39", "AGE": 83.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1975", "DAYS_TO_BIRTH": -30539.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "11/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 64.93079528, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 64.93079528, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 64.93079528, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2IO-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2914, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.43333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 222.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin + Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 84, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0UM": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a7c565fc-c711-4b63-9549-4cd74d1f57c2", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2644", "DAYS_TO_BIRTH": -23400.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.92507479, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.92507479, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 47.80221587, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 47.80221587, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0UM-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5523, "MSI_SENSOR_SCORE": 28.86, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 15.73333333, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": null }, "treatments": [ { "START_DATE": 1552, "STOP_DATE": 1659.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "307", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1842.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1530, "STOP_DATE": 1658.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "86", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 516.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1890, "STOP_DATE": 2050.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "150", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2550.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1530, "STOP_DATE": 1658.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "96", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 576.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1890, "STOP_DATE": 2050.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "110", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1870.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1870, "STOP_DATE": 1870.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": "Mets To Brain", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 1.0, "RADIATION_DOSAGE": 2400.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1743, "STOP_DATE": 1743.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": "Mets To Brain", "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 1.0, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-E6-A8L9": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "EB642568-30D4-4805-A295-BDA314CCAAAF", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1013", "DAYS_TO_BIRTH": -22333.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/3/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 78.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.30374462, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.30374462, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.30374462, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.30374462, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-E6-A8L9-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E6", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.361, "MSI_SENSOR_SCORE": 0.61, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 571.0 }, "treatments": [ { "START_DATE": 75, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 68, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 106, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 30.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A1Y8": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "de4e13c8-5ad0-46d2-ae54-b9ca22b939d8", "AGE": 87.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1147", "DAYS_TO_BIRTH": -31971.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.70917579, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.70917579, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.70917579, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.70917579, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A1Y8-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.302, "MSI_SENSOR_SCORE": 0.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 290.0 }, "treatments": [] }, "TCGA-AX-A1C9": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2714af93-e200-4b4a-9df8-7d837b37489f", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "802", "DAYS_TO_BIRTH": -26903.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.36683434, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.36683434, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.36683434, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1C9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5573, "MSI_SENSOR_SCORE": 8.72, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 32.36666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 93.0 }, "treatments": [] }, "TCGA-EY-A1GV": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e3e39474-c2b0-45af-bbe1-4c24f17cc284", "AGE": 75.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "481", "DAYS_TO_BIRTH": -27581.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.81352533, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.81352533, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.81352533, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.81352533, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GV-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2862, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.133333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 179.0 }, "treatments": [ { "START_DATE": 48, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3615.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 48, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1915.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 134, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 23.0, "RADIATION_DOSAGE": 3960.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 168, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 900.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 160, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0V8": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2b76cc9c-c379-43e4-9c3f-56197a3353be", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2544", "DAYS_TO_BIRTH": -24981.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Native Hawaiian or Other Pacific Islander", "RADIATION_THERAPY": "Yes", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 83.63743959, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 83.63743959, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 83.63743959, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 83.63743959, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0V8-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2631, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.533333333, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 284.0 }, "treatments": [] }, "TCGA-AX-A1C5": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "caebdce0-f954-471a-ac63-5daaa2e76d97", "AGE": 47.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1001", "DAYS_TO_BIRTH": -17383.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 107.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.90922839, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.90922839, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.90922839, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.90922839, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1C5-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6802, "MSI_SENSOR_SCORE": 13.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 28.06666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 9.0 }, "treatments": [ { "START_DATE": 237, "STOP_DATE": 291.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11N": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ca594f56-9c68-4b7e-84b2-669f1004e3a4", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1876", "DAYS_TO_BIRTH": -25442.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.67603643, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.67603643, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.67603643, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.67603643, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11N-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.259, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 63.86666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-AP-A05N": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "08b11e0e-5b8e-45ea-9b6b-30e3185b03d7", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "239", "DAYS_TO_BIRTH": -21254.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 123.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 23.86823158, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.86823158, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.86823158, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.86823158, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A05N-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5364, "MSI_SENSOR_SCORE": 12.59, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.633333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 91, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A1CI": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "fba80122-d8b2-4d8d-a032-9767e8160f9f", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2600", "DAYS_TO_BIRTH": -22582.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 85.4785153, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 85.4785153, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 85.4785153, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1CI-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.333, "MSI_SENSOR_SCORE": 1.46, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.033333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-D1-A169": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9a599f57-0e8d-4e1f-a181-791f5fdeadb7", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "1135", "DAYS_TO_BIRTH": -23238.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 102.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.31465957, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.31465957, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.06282671, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A169-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2669, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 42.0 }, "treatments": [ { "START_DATE": 31, "STOP_DATE": 142.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2170.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 31, "STOP_DATE": 142.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3730.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 533, "STOP_DATE": 1135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 29.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 10300.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 533, "STOP_DATE": 554.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1140.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A0JU": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "65ef7168-69c6-4910-a141-d7558d0027c9", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1802", "DAYS_TO_BIRTH": -21159.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 137.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 59.24318638, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 59.24318638, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 59.24318638, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0JU-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8228, "MSI_SENSOR_SCORE": 20.47, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.63333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-D1-A179": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "37d5c1d9-3ff5-44fe-afdc-ff430a0f3510", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "206", "DAYS_TO_BIRTH": -28037.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 95.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 14.72860571, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 14.72860571, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 14.03820232, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 14.03820232, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A179-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2998, "MSI_SENSOR_SCORE": 1.7, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 240.0 }, "treatments": [ { "START_DATE": 55, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3124.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 55, "STOP_DATE": 160.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2170.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-PG-A914": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "FF6B5FC8-0572-4B58-B3A5-BCDA41BADBC8", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "687", "DAYS_TO_BIRTH": -26992.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/23/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8461/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.58605385, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.58605385, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.58605385, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.58605385, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-PG-A914-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3571, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.566666667, "TISSUE_SOURCE_SITE": "Montefiore Medical Center", "TBL_SCORE": 776.0 }, "treatments": [ { "START_DATE": 133, "STOP_DATE": 150.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0RY": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f299ad43-bb16-46ce-9617-48cc6c6f29e7", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "469", "DAYS_TO_BIRTH": -24952.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 118.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 15.41900911, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 15.41900911, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 15.41900911, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 15.41900911, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0RY-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2835, "MSI_SENSOR_SCORE": 0.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-EY-A1H0": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "c71e0986-56c0-45f4-be8d-2236e4418604", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "588", "DAYS_TO_BIRTH": -20937.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.331295, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.331295, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.331295, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1H0-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.941, "MSI_SENSOR_SCORE": 23.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.43333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 91, "STOP_DATE": 315.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3380.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 91, "STOP_DATE": 315.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1660.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 462, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 244, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 540.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 202, "STOP_DATE": 246.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 30.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 202, "STOP_DATE": 241.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 174, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 4", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 540.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0GD": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1486a031-b74d-4976-8b0b-4569e6978f49", "AGE": 75.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "98", "DAYS_TO_BIRTH": -27399.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/16/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 112.535753, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 112.535753, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 112.535753, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 112.535753, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GD-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.285, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 192.0 }, "treatments": [] }, "TCGA-D1-A1O0": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "A98BBE29-8817-4380-A738-3C1BF9F8E0CC", "AGE": 77.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "63", "DAYS_TO_BIRTH": -28162.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 117.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.071210179, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.071210179, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.071210179, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.071210179, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A1O0-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3044, "MSI_SENSOR_SCORE": 0.6, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 276.0 }, "treatments": [] }, "TCGA-B5-A0JT": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d5f2bae1-7cd1-49bf-ae41-12d2aa44408e", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1682", "DAYS_TO_BIRTH": -23041.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 119.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 55.29802413, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 55.29802413, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 55.29802413, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 55.29802413, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0JT-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2672, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 45, "STOP_DATE": 221.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A3FZ": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5262D82D-FC43-41F4-9B23-C9AC6F237FF0", "AGE": 33.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2", "DAYS_TO_BIRTH": -12331.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 113.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.197258112, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.197258112, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.197258112, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3FZ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.336, "MSI_SENSOR_SCORE": 1.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.333333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 44.0 }, "treatments": [] }, "TCGA-EY-A2ON": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "BEE58BE0-C2B0-4CDC-ADF6-B99243DA586A", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "409", "DAYS_TO_BIRTH": -22624.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/15/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 100.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 20.05457474, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 20.05457474, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 7.430055561, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A2ON-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2803, "MSI_SENSOR_SCORE": 0.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.4, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 217.0 }, "treatments": [ { "START_DATE": 63, "STOP_DATE": 236.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 63, "STOP_DATE": 236.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 254, "STOP_DATE": 352.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 373, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A177": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e8c58d8b-51d7-4599-af79-469ee6f269db", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "548", "DAYS_TO_BIRTH": -25602.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 53.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.01624092, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.01624092, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 11.40809416, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.40809416, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A177-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.0196, "MSI_SENSOR_SCORE": 31.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 26.76666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 514, "STOP_DATE": 548.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 67, "STOP_DATE": 71.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0YU": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "957ac10a-7365-47b1-bbed-47e5d42fbfdf", "AGE": 37.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "451", "DAYS_TO_BIRTH": -13644.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 107.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.82723477, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.82723477, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.82723477, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.82723477, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0YU-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2784, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.6, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-BG-A0MK": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1F9B1B71-8753-4CD5-A585-708BEA8FF1FA", "AGE": 52.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -19034.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/29/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 43.29815564, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 43.29815564, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 43.29815564, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0MK-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3119, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.7, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 108, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 50.4, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 153, "STOP_DATE": 158.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 2.0, "RADIATION_DOSAGE": 10.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A052": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "bd4284a7-260d-48b3-9b48-a1c578c30d27", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -21721.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 126.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 21.99427952, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 21.99427952, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.9532827, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A052-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2738, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 325.0 }, "treatments": [ { "START_DATE": 406, "STOP_DATE": 462.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "300", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 900.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 406, "STOP_DATE": 469.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "550", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 7700.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 70, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2100.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 70, "STOP_DATE": 187.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2550.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0LF": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "748e38b1-2ead-4a0a-8881-d640617b856b", "AGE": 82.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "2859", "DAYS_TO_BIRTH": -30027.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 93.99349048, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 93.99349048, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 93.99349048, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LF-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2706, "MSI_SENSOR_SCORE": 0.66, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.1, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 406.0 }, "treatments": [] }, "TCGA-EY-A72D": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "A12DF3D7-C560-4E7D-A482-1025A6E5B465", "AGE": 87.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "179", "DAYS_TO_BIRTH": -31818.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/9/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 106.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 5.884867015, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 5.884867015, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 5.884867015, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 5.884867015, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A72D-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 23.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3729, "MSI_SENSOR_SCORE": 1.6, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 142.0 }, "treatments": [] }, "TCGA-A5-A1OJ": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0f361166-2b7d-4ef5-9f8f-ee2488548a0b", "AGE": 31.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1006", "DAYS_TO_BIRTH": -11635.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 94.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 33.07361015, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 33.07361015, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 33.07361015, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 33.07361015, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-A5-A1OJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2921, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.066666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-FI-A2F8": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "601734DA-2D11-4745-A260-0965F58AADEA", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "933", "DAYS_TO_BIRTH": -23649.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 99.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.67363645, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.67363645, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.67363645, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.67363645, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2F8-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3111, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 315.0 }, "treatments": [ { "START_DATE": 36, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 36, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 36, "STOP_DATE": 141.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0UJ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ff82548a-f1bb-4daa-a8f7-b3831b5843ad", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2506", "DAYS_TO_BIRTH": -25149.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 52.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 82.38813821, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 82.38813821, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 82.38813821, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 82.38813821, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0UJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3517, "MSI_SENSOR_SCORE": 5.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 52.83333333, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-AP-A05O": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "49431740-7ed1-4c67-8d66-730629825895", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "384", "DAYS_TO_BIRTH": -24978.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 103.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.62451918, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.62451918, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 11.17795969, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.17795969, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A05O-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5925, "MSI_SENSOR_SCORE": 25.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 118, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 620.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 97, "STOP_DATE": 146.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1210.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 104, "STOP_DATE": 132.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FI-A2CX": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "DFFC7091-BC27-452C-AD94-1EE214107593", "AGE": 82.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2031", "DAYS_TO_BIRTH": -30224.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 52.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.77187099, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.77187099, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 66.77187099, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.77187099, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2CX-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2871, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 33.0 }, "treatments": [] }, "TCGA-EY-A1GH": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a45a2343-f425-4e62-9049-7782733b6234", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "710", "DAYS_TO_BIRTH": -25802.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 117.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.34220995, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.34220995, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.34220995, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.34220995, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GH-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2897, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0UA": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a1a0177d-e670-4f2f-a99d-6f668a2f9e8a", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2687", "DAYS_TO_BIRTH": -24872.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 114.9028504, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 114.9028504, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 17.09570306, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.09570306, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0UA-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5364, "MSI_SENSOR_SCORE": 16.89, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.73333333, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-EY-A547": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3424120F-248F-451A-948C-E320C19D1B19", "AGE": 75.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "545", "DAYS_TO_BIRTH": -27686.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/27/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 108.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.91761186, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.91761186, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.91761186, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.91761186, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A547-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4834, "MSI_SENSOR_SCORE": 6.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.933333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 83.0 }, "treatments": [ { "START_DATE": 171, "STOP_DATE": 185.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A0JR": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a766d113-bc3f-4448-a4e5-f391fb0c0e22", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1731", "DAYS_TO_BIRTH": -26814.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "12/7/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 105.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 56.90896538, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 56.90896538, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 56.90896538, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 56.90896538, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0JR-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8081, "MSI_SENSOR_SCORE": 26.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 19.1, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BS-A0UL": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5428c4b2-37c2-4f8c-a474-39fe1aacb26b", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2481", "DAYS_TO_BIRTH": -19982.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Native Hawaiian or Other Pacific Islander", "RADIATION_THERAPY": "No", "WEIGHT": 114.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 81.56622941, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 81.56622941, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 81.56622941, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 81.56622941, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0UL-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4699, "MSI_SENSOR_SCORE": 12.99, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 13.0, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-BG-A0LX": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ac1d3946-fe6c-4bd8-b02c-638799cb0f67", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "614", "DAYS_TO_BIRTH": -20928.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/1/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 96.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.18608015, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.18608015, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.18608015, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.18608015, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0LX-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8188, "MSI_SENSOR_SCORE": 26.46, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 15.0, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": 96.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A064": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "633e6994-3e8b-4c0b-9b79-06cf4ab6f9bc", "AGE": 81.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1517", "DAYS_TO_BIRTH": -29625.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/29/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 48.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 49.87342605, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 49.87342605, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 49.87342605, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 49.87342605, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A064-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5467, "MSI_SENSOR_SCORE": 15.94, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 8.733333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-AX-A05S": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3a4a6aff-4720-41fc-a114-85f38610ebb1", "AGE": 81.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -29928.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 48.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 13.57793339, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 13.57793339, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.11220699, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A05S-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.846, "MSI_SENSOR_SCORE": 31.68, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 16.5, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-DF-A2KS": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "46E064CC-933B-444B-9E15-80FADBC53487", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "3318", "DAYS_TO_BIRTH": -25313.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": null, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/15/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 109.0837361, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 109.0837361, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 109.0837361, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 74.8594536, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DF-A2KS-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DF", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3045, "MSI_SENSOR_SCORE": 0.71, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.9, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research", "TBL_SCORE": 156.0 }, "treatments": [ { "START_DATE": 104, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 50, "STOP_DATE": 64.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A05W": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "87e44856-eb9a-475f-96b1-047b7f77b0da", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2450", "DAYS_TO_BIRTH": -22200.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 80.5470625, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 80.5470625, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 80.5470625, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 80.5470625, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A05W-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2715, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.2, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 8.0 }, "treatments": [] }, "TCGA-BG-A0VZ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "edee2bf5-284c-4d77-823a-d037fe4c4b9e", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1601", "DAYS_TO_BIRTH": -21414.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/17/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 109.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.63503962, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.63503962, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 52.63503962, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.63503962, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0VZ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.757, "MSI_SENSOR_SCORE": 22.9, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.0, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 103, "STOP_DATE": 175.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 114, "STOP_DATE": 145.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 103, "STOP_DATE": 165.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0U5": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "c306d7e8-5486-41d3-84dd-9311ce3e2069", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2935", "DAYS_TO_BIRTH": -27945.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 96.49209324, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 96.49209324, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 96.49209324, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 96.49209324, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0U5-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2767, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-DI-A0WH": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3dab68d3-232c-4b4f-81a4-ca8f72d69a43", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "496", "DAYS_TO_BIRTH": -23692.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 107.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.30667061, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.30667061, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.30667061, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.30667061, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DI-A0WH-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7904, "MSI_SENSOR_SCORE": 25.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 19.53333333, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 90, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 3000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A16J": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4db4d048-016a-4186-a519-bfbad237762f", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "910", "DAYS_TO_BIRTH": -22319.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 130.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.91748036, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.91748036, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.91748036, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.91748036, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16J-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2648, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.5, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 27.0 }, "treatments": [ { "START_DATE": 89, "STOP_DATE": 195.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 5160.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 89, "STOP_DATE": 195.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2630.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 53, "STOP_DATE": 61.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A0J0": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1c7b41fc-daa7-4a6e-b553-aff73e8ebac6", "AGE": 47.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1220", "DAYS_TO_BIRTH": -17466.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 53.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 40.10914949, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 40.10914949, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 40.10914949, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 40.10914949, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A0J0-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3, "MSI_SENSOR_SCORE": 1.72, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 518.4333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-B5-A11Z": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "cc141997-edab-4aae-a056-0c079eaa7362", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "528", "DAYS_TO_BIRTH": -22505.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.35871388, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.35871388, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.35871388, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.35871388, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11Z-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2746, "MSI_SENSOR_SCORE": 0.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.733333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-AP-A05D": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f7e06a10-74ca-4f52-a944-b3f22c016998", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1758", "DAYS_TO_BIRTH": -24597.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 98.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 57.79662689, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 57.79662689, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 57.79662689, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 57.79662689, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A05D-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2783, "MSI_SENSOR_SCORE": 0.34, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.1, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 281.0 }, "treatments": [ { "START_DATE": 100, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 395.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 194, "STOP_DATE": 259.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1380.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 194, "STOP_DATE": 259.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2165.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 99, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 135, "STOP_DATE": 139.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 540.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0R8": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "06d16b6b-9ca6-4cec-a785-f27aa4323cec", "AGE": 81.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "596", "DAYS_TO_BIRTH": -29777.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/17/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.59430582, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.59430582, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 1.380806786, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 1.380806786, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0R8-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2859, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.566666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 86, "STOP_DATE": 100.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A8CW": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "43E08773-767E-4B81-94E4-8848565C23E9", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "4", "DAYS_TO_BIRTH": -23554.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/27/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": 134.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.131505408, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.131505408, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.131505408, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A8CW-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8784, "MSI_SENSOR_SCORE": 24.7, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 22.13333333, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 26.0 }, "treatments": [] }, "TCGA-AX-A2HG": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7A2CF5CE-8317-4FFF-946E-B9937AFAB815", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1163", "DAYS_TO_BIRTH": -20771.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 115.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.23519742, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.23519742, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.23519742, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.23519742, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2HG-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9147, "MSI_SENSOR_SCORE": 20.23, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 28.9, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-FI-A2EU": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4284A85D-D9B6-40EE-AAC4-C2C03554528E", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2941", "DAYS_TO_BIRTH": -24837.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 96.68935135, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 96.68935135, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 96.68935135, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 96.68935135, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2EU-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3271, "MSI_SENSOR_SCORE": 1.87, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 193.0 }, "treatments": [ { "START_DATE": 44, "STOP_DATE": 166.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 44, "STOP_DATE": 1971.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A54A": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "75783DBE-E18C-4535-B9EB-2AFFD320E098", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "447", "DAYS_TO_BIRTH": -24822.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/27/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.9", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 70.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.69572936, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.69572936, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.69572936, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.69572936, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A54A-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3081, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.4, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 231.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 259.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 49, "STOP_DATE": 259.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 140, "STOP_DATE": 176.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-FI-A2F4": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "43476C88-86BC-4A65-9327-F0D24A41C971", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2230", "DAYS_TO_BIRTH": -23621.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 73.31426505, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.31426505, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 73.31426505, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 73.31426505, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-FI-A2F4-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "FI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7492, "MSI_SENSOR_SCORE": 19.52, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 64.13333333, "TISSUE_SOURCE_SITE": "Washington University", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-A5-A0G9": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "45d58088-d3f4-4eb0-b75c-bcb98c0981dc", "AGE": 79.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "2540", "DAYS_TO_BIRTH": -29122.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 83.50593418, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 83.50593418, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 83.50593418, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 83.50593418, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0G9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6507, "MSI_SENSOR_SCORE": 20.59, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.76666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-B5-A11W": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f5bd3902-ff7f-4233-8f74-beef3676af9a", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "593", "DAYS_TO_BIRTH": -22365.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/4/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 102.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.49567676, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.49567676, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.49567676, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.49567676, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11W-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2663, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.433333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 9.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 91.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0M0": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8bf0b156-6eb4-45e8-9cbb-0979efbea898", "AGE": 66.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "588", "DAYS_TO_BIRTH": -24427.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/1/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 117.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.331295, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.331295, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.331295, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.331295, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0M0-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4648, "MSI_SENSOR_SCORE": 9.83, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.6, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-DF-A2KZ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3B218AB7-5C2E-4458-A0AC-5152EC3D2B94", "AGE": 87.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "826", "DAYS_TO_BIRTH": -31973.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/11/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.15586679, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.15586679, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.15586679, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DF-A2KZ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DF", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.715, "MSI_SENSOR_SCORE": 16.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 20.13333333, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-AX-A060": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d1b615f4-50c9-497b-8a69-8de78aa17e09", "AGE": 77.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1075", "DAYS_TO_BIRTH": -28472.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "American Indian or Alaska Native", "RADIATION_THERAPY": "Yes", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.34207844, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.34207844, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.34207844, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.34207844, "GENETIC_ANCESTRY_LABEL": "AMR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A060-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": null, "MSI_SENSOR_SCORE": 35.52, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 24.8, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-AP-A05J": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "38f9fe64-de79-498c-b3ca-1c83af0ed72a", "AGE": 66.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1122", "DAYS_TO_BIRTH": -24119.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.88726699, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.88726699, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.88726699, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.88726699, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A05J-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2622, "MSI_SENSOR_SCORE": 0.33, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 224.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2562.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 84, "STOP_DATE": 189.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1944.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 92, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11Q": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "af852215-5a4b-44b4-8e8e-b887dcb3cf8c", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "976", "DAYS_TO_BIRTH": -23538.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 32.08731959, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 32.08731959, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 32.08731959, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 32.08731959, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11Q-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2746, "MSI_SENSOR_SCORE": 0.49, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 20.0 }, "treatments": [ { "START_DATE": 118, "STOP_DATE": 529.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "40", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 76, "STOP_DATE": 843.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11E": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "38a3ea92-8965-4bda-9dbd-144832975cdd", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1820", "DAYS_TO_BIRTH": -19458.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 52.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 59.83496071, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 59.83496071, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 59.83496071, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 59.83496071, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11E-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3566, "MSI_SENSOR_SCORE": 5.48, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 303.0333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 26.0 }, "treatments": [] }, "TCGA-B5-A1MS": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "B2AA0220-6387-4EEA-B6D4-A4FA0F15B2D9", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22068.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/10/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 102.3112076, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 102.3112076, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 88.96340862, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A1MS-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3021, "MSI_SENSOR_SCORE": 0.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 214.0 }, "treatments": [ { "START_DATE": 2419, "STOP_DATE": 2566.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 2419, "STOP_DATE": 2566.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 2419, "STOP_DATE": 2566.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Targeted Molecular Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Bevacizumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 2825, "STOP_DATE": 2830.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Ixabepilone", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 2916, "STOP_DATE": 2985.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Gemcitabine", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 3041, "STOP_DATE": 3090.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Topotecan", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 2718, "STOP_DATE": 2752.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 2782, "STOP_DATE": 2802.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 3500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0G1": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "53707bb3-426a-43cb-830f-3eeed930295f", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24477.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 106.8810205, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 106.8810205, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 106.8810205, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 106.8810205, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0G1-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3108, "MSI_SENSOR_SCORE": 1.74, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 363.5333333, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 72, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3TW": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9EE944EF-4293-4228-B750-CC34AB388EB3", "AGE": 78.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "513", "DAYS_TO_BIRTH": -28559.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 55.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.8655686, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.8655686, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.8655686, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.8655686, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3TW-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4195, "MSI_SENSOR_SCORE": 0.43, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.8, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 456.0 }, "treatments": [ { "START_DATE": 93, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0V6": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a9b6cd65-f042-4073-9000-4143a2c55373", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2725", "DAYS_TO_BIRTH": -20369.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 89.58805931, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 89.58805931, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 89.58805931, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 89.58805931, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0V6-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2612, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-B5-A0JZ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d129ebb4-db21-4342-8d9b-318a67aefa56", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2173", "DAYS_TO_BIRTH": -22106.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 87.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.44031298, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.44031298, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.70398133, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0JZ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7918, "MSI_SENSOR_SCORE": 28.87, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 16.7, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 157, "STOP_DATE": 325.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 7.0, "PRESCRIBED_DOSE": "327", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 157, "STOP_DATE": 325.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 7.0, "PRESCRIBED_DOSE": "744", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 390, "STOP_DATE": 424.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 76, "STOP_DATE": 124.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 5400.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A549": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3D9828AE-EB65-4D0A-8D7A-CC09E98B5E99", "AGE": 78.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "605", "DAYS_TO_BIRTH": -28570.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/27/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.9", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.89019298, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.89019298, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.89019298, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.89019298, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-EY-A549-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8695, "MSI_SENSOR_SCORE": 20.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 44.5, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 198, "STOP_DATE": 212.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A3G4": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "83F2CD11-0DD7-47A6-B4B3-8212FAAC94BB", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "9", "DAYS_TO_BIRTH": -22099.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/6/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Native Hawaiian or Other Pacific Islander", "RADIATION_THERAPY": null, "WEIGHT": 107.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.295887168, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.295887168, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.295887168, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-AX-A3G4-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 13.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3004, "MSI_SENSOR_SCORE": 0.39, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 380.0 }, "treatments": [] }, "TCGA-AJ-A3BD": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "AB68CD1B-5075-4B30-A829-D6D0F95871CB", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1039", "DAYS_TO_BIRTH": -20998.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8460/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.15852977, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.15852977, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.15852977, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.15852977, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3BD-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2845, "MSI_SENSOR_SCORE": 0.05, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.6, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 355.0 }, "treatments": [ { "START_DATE": 37, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 37, "STOP_DATE": 125.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 118, "STOP_DATE": 156.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 168, "STOP_DATE": 186.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A0LO": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a081da6f-51f3-4555-a6b8-736f8c6cda39", "AGE": 45.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -16493.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 67.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 33.40237367, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 33.40237367, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 16.96419765, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 16.96419765, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LO-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.272, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 639, "STOP_DATE": 671.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 682, "STOP_DATE": 684.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Local Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 4.0, "RADIATION_DOSAGE": 1800.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A1GX": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a7fd6522-8953-461f-9e5f-fdeb7d180d46", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "197", "DAYS_TO_BIRTH": -27962.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 69.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 37.05164875, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.05164875, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 24.42712957, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 24.42712957, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GX-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3021, "MSI_SENSOR_SCORE": 0.43, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.433333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 10.0 }, "treatments": [] }, "TCGA-AJ-A3EM": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "C856E031-BBD0-431F-B44F-B3AD9B39AF7B", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "677", "DAYS_TO_BIRTH": -25557.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.25729033, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.25729033, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.25729033, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.25729033, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3EM-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3264, "MSI_SENSOR_SCORE": 0.43, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.7, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 461.0 }, "treatments": [] }, "TCGA-BG-A0VX": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6c2a0f37-49cd-4fd0-b126-58b35f9121df", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1043", "DAYS_TO_BIRTH": -21425.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 157.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.29003518, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.29003518, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.29003518, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.29003518, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0VX-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2605, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.9, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 77, "STOP_DATE": 104.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 2350.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A168": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "41893e97-7e90-4b03-b738-260f288ade4c", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "1098", "DAYS_TO_BIRTH": -24586.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.09823454, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.09823454, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.09823454, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.09823454, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A168-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2875, "MSI_SENSOR_SCORE": 0.24, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 41, "STOP_DATE": 48.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A22U": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "30BC72D5-07B5-48D2-B025-BBA9BCF2F09F", "AGE": 83.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1407", "DAYS_TO_BIRTH": -30557.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 46.25702732, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 46.25702732, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 46.25702732, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 46.25702732, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A22U-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4032, "MSI_SENSOR_SCORE": 3.26, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 464.1666667, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 16.0 }, "treatments": [ { "START_DATE": 49, "STOP_DATE": 84.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 45.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A1C4": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "40ce24c6-b331-4be2-baf9-2fa7dc855f9b", "AGE": 52.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "404", "DAYS_TO_BIRTH": -19209.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/12/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 115.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.28204622, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.28204622, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.28204622, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1C4-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.0651, "MSI_SENSOR_SCORE": 25.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 28.76666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 203, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Combination", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A1GS": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "c10b2885-70ea-4d32-bc48-8b85530df702", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "459", "DAYS_TO_BIRTH": -26012.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 22.02715587, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 22.02715587, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 22.02715587, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GS-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3141, "MSI_SENSOR_SCORE": 1.42, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.86666667, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 261.0 }, "treatments": [ { "START_DATE": 193, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 39, "STOP_DATE": 95.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1100.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 39, "STOP_DATE": 95.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "6", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2660.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3BG": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "77ED36AD-222F-4693-8668-0ECF9073D6E8", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "550", "DAYS_TO_BIRTH": -23861.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.08199362, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.08199362, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 15.78064898, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 15.78064898, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3BG-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.1057, "MSI_SENSOR_SCORE": 25.85, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 42.96666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 14.0 }, "treatments": [ { "START_DATE": 67, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 67, "STOP_DATE": 247.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 550, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 550, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 123, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 6000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A15W": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d6562acf-6d82-4f08-a779-82cdc5df16f9", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "915", "DAYS_TO_BIRTH": -21545.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 126.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 30.08186212, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 30.08186212, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 30.08186212, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 30.08186212, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A15W-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2687, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1080.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 70, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1800.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 198, "STOP_DATE": 232.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 239, "STOP_DATE": 241.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 2.0, "RADIATION_DOSAGE": 1000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0TG": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "13f31bcb-befd-4ed2-adc0-dc9e9ce52b75", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2371", "DAYS_TO_BIRTH": -22043.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 77.94983069, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 77.94983069, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 77.94983069, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 77.94983069, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0TG-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2899, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 61, "STOP_DATE": 93.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A23N": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5D39E9A2-1073-4DB2-B02E-DB05D59563A7", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "33", "DAYS_TO_BIRTH": -25772.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/4/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 14.43271855, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 14.43271855, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 14.43271855, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A23N-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.328, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.5, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 230.0 }, "treatments": [ { "START_DATE": 89, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 89, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 165, "STOP_DATE": 206.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "radiographic progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 31.0, "RADIATION_DOSAGE": 6200.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A2HH": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "52FEF8A9-6860-48BD-B992-A56CCAD1243C", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "540", "DAYS_TO_BIRTH": -21924.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/31/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.7532301, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.7532301, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.7532301, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2HH-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2913, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.3, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 12.0 }, "treatments": [] }, "TCGA-AX-A0IW": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "db21fccf-40cb-4235-a34d-336a03b8c8f4", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1149", "DAYS_TO_BIRTH": -24488.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 61.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.77492849, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.77492849, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.77492849, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.77492849, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A0IW-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2889, "MSI_SENSOR_SCORE": 0.95, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 316.0 }, "treatments": [] }, "TCGA-BS-A0U8": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "fb7475df-30cc-4316-b9ac-37cbeeb6ba2b", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2963", "DAYS_TO_BIRTH": -20402.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 82.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 97.41263109, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 97.41263109, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 97.41263109, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 97.41263109, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0U8-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8033, "MSI_SENSOR_SCORE": 24.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.2, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 24.0 }, "treatments": [ { "START_DATE": 105, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "89", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 534.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 105, "STOP_DATE": 210.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "99", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 594.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 43, "STOP_DATE": 86.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 29.0, "RADIATION_DOSAGE": 5740.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Combination", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A3KW": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5F764AC1-3DE7-4CFD-A77A-D21BAA418834", "AGE": 72.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "497", "DAYS_TO_BIRTH": -26492.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.33954696, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.33954696, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.33954696, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.33954696, "GENETIC_ANCESTRY_LABEL": "EUR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-EO-A3KW-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3047, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 340.0 }, "treatments": [] }, "TCGA-AP-A0LI": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e1e8dc66-467c-48a5-be56-3db4f665b9f1", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "2972", "DAYS_TO_BIRTH": -24573.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 86.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 97.70851826, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 97.70851826, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 97.70851826, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 97.70851826, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LI-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.27, "MSI_SENSOR_SCORE": 0.27, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.566666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 385.0 }, "treatments": [ { "START_DATE": 185, "STOP_DATE": 300.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2016.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 185, "STOP_DATE": 300.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2382.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 115, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0TE": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "09066fbf-6a1d-46c9-a4c5-c53340c3d1ba", "AGE": 35.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -12983.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "11/19/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.9", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.9", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 91.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 4.799947398, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 4.799947398, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 1.906828418, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0TE-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4882, "MSI_SENSOR_SCORE": 4.84, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.0, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 65.0 }, "treatments": [ { "START_DATE": 28, "STOP_DATE": 75.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "45", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 135.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 104, "STOP_DATE": 135.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Topotecan", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "4", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 3.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 12.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 93, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "308", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 924.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 93, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 240.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 28, "STOP_DATE": 75.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 480.0, "TOTAL_DOSE_UNITS": "mg/m2", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 111, "STOP_DATE": 127.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Palliative", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 13.0, "RADIATION_DOSAGE": 2600.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A17H": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6c526c42-2fb2-4dfa-8a3d-5651dd600ac7", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "852", "DAYS_TO_BIRTH": -22389.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 96.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 28.01065194, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 28.01065194, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 28.01065194, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 28.01065194, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17H-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8869, "MSI_SENSOR_SCORE": 30.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 22.26666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-D1-A16I": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "548ec160-4183-459f-8393-f4b4672a3251", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -22836.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 11.50672321, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.50672321, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.50672321, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.50672321, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16I-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2793, "MSI_SENSOR_SCORE": 0.77, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 409.0 }, "treatments": [ { "START_DATE": 88, "STOP_DATE": 95.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A0K0": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "29c8f468-5ac1-4d6c-8376-e36e6d246926", "AGE": 48.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1478", "DAYS_TO_BIRTH": -17810.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 140.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 48.59124832, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 48.59124832, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 48.59124832, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 48.59124832, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0K0-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2477, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BK-A4ZD": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1C4D225E-E065-4E26-9413-78F54A7E0CF5", "AGE": 42.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "506", "DAYS_TO_BIRTH": -15536.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/28/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 142.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.63543413, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.63543413, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.63543413, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.63543413, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-BK-A4ZD-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3226, "MSI_SENSOR_SCORE": 0.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.733333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 114.0 }, "treatments": [] }, "TCGA-AX-A062": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4af65655-a3bd-4252-9b2f-2b2c4394f95c", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1399", "DAYS_TO_BIRTH": -19643.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 122.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 45.9940165, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 45.9940165, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 45.9940165, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 45.9940165, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A062-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2416, "MSI_SENSOR_SCORE": 0.15, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.833333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-B5-A5OC": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "AE8A4958-5407-4C01-93C3-8090862533AE", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1249", "DAYS_TO_BIRTH": -26109.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 41.0625637, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 41.0625637, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 41.0625637, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A5OC-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 3.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6411, "MSI_SENSOR_SCORE": 13.96, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 32.6, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 111, "STOP_DATE": 106.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 105, "STOP_DATE": 115.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 45.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "gy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A1E1": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2b85b84f-e680-4b5c-93ea-3c71567227e8", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1395", "DAYS_TO_BIRTH": -27072.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 45.8625111, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 45.8625111, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 45.8625111, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 45.8625111, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1E1-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7298, "MSI_SENSOR_SCORE": 12.89, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 18.56666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-KP-A3W1": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3BCE9803-E74C-462E-BD40-8EC337A66F3A", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "288", "DAYS_TO_BIRTH": -27902.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "7/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "Yes", "WEIGHT": 66.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 9.468389388, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 9.468389388, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 9.468389388, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 9.468389388, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-KP-A3W1-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "KP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 31.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2968, "MSI_SENSOR_SCORE": 0.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "British Columbia Cancer Agency", "TBL_SCORE": 292.0 }, "treatments": [] }, "TCGA-A5-A0R6": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "39609d3c-f5d3-4bc4-b356-1403c6dd1cb5", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1153", "DAYS_TO_BIRTH": -23449.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/27/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.9064339, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.9064339, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.9064339, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 31.59417431, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-A5-A0R6-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 17.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2949, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.6, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 197.0 }, "treatments": [ { "START_DATE": 82, "STOP_DATE": 183.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "295", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1475.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 309, "STOP_DATE": 330.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A2QK": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "DE5ABE44-6D9D-4797-A57A-5ADFD71383F0", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "643", "DAYS_TO_BIRTH": -23945.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 119.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.13949436, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.13949436, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 19.92306934, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 19.92306934, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A2QK-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2833, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.333333333, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 44.0 }, "treatments": [ { "START_DATE": 643, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 653, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 48, "STOP_DATE": 62.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A3G7": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "71ED7D6D-8C44-4D37-A04A-7A78DF21E514", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "9", "DAYS_TO_BIRTH": -26187.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/7/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.295887168, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.295887168, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.295887168, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3G7-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3123, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 215.0 }, "treatments": [] }, "TCGA-D1-A17F": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "129a49d4-edb8-4a1d-aabb-51b9ad5a8dd1", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "39", "DAYS_TO_BIRTH": -25116.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.28217773, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.28217773, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.28217773, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.28217773, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17F-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3968, "MSI_SENSOR_SCORE": 4.57, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.333333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-AX-A1C7": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "755d7ab7-4563-408a-9135-f852048af975", "AGE": 77.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1054", "DAYS_TO_BIRTH": -28198.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.65167505, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.65167505, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 12.8217773, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1C7-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3124, "MSI_SENSOR_SCORE": 0.77, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 263.0 }, "treatments": [ { "START_DATE": 434, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Topotecan", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0UV": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "b19425ab-a82f-4c2a-bf58-d1bd30511d74", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2228", "DAYS_TO_BIRTH": -20266.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Native Hawaiian or Other Pacific Islander", "RADIATION_THERAPY": "No", "WEIGHT": 112.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 73.24851235, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.24851235, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 73.24851235, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 73.24851235, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0UV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2839, "MSI_SENSOR_SCORE": 0.85, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 300.6666667, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 28.0 }, "treatments": [] }, "TCGA-A5-A0GA": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "71fed998-8fac-4e6b-b38a-22c83e05e958", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24659.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/13/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 17.85185916, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 17.85185916, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.85185916, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GA-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5237, "MSI_SENSOR_SCORE": 15.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.06666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 10.0 }, "treatments": [ { "START_DATE": 67, "STOP_DATE": 172.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "348", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2088.0, "TOTAL_DOSE_UNITS": "[iu]/mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 67, "STOP_DATE": 172.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "470", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2820.0, "TOTAL_DOSE_UNITS": "[iu]/mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 300, "STOP_DATE": 402.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 7.0, "PRESCRIBED_DOSE": "60", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 3.0, "REGIMEN_INDICATION": "Other, Specify In Notes", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 420.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A0MQ": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "12d36a1d-9922-4311-bbda-71f32ac2c03b", "AGE": 71.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1817", "DAYS_TO_BIRTH": -26284.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/9/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 101.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 59.73633166, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 59.73633166, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 59.73633166, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0MQ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8335, "MSI_SENSOR_SCORE": 23.55, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 20.2, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-DF-A2KV": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "59CEBAE6-632D-4632-B695-C48AE46B2E67", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "2717", "DAYS_TO_BIRTH": -20160.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "10/14/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": null, "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 89.32504849, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 89.32504849, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 89.32504849, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DF-A2KV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DF", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.288, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 44.43333333, "TISSUE_SOURCE_SITE": "Ontario Institute for Cancer Research", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-BG-A0YV": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d8e57746-37a1-482a-a3d3-a11bd00cdc11", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "382", "DAYS_TO_BIRTH": -24567.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/16/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 54.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 12.55876648, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 12.55876648, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 12.55876648, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 12.55876648, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0YV-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2924, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.366666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 136.0 }, "treatments": [] }, "TCGA-AX-A0J1": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ec7a9d74-8b3f-4747-8926-1739a016ab2b", "AGE": 80.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2354", "DAYS_TO_BIRTH": -29501.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 57.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 77.3909327, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 77.3909327, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 77.3909327, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 77.3909327, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A0J1-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7195, "MSI_SENSOR_SCORE": 29.85, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 171.4, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-D1-A102": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f9cf4125-0db3-4b66-b51b-bc2f0240c9ef", "AGE": 49.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "135", "DAYS_TO_BIRTH": -17991.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/8/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 122.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 4.438307525, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 4.438307525, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 4.438307525, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 4.438307525, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A102-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 8.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2975, "MSI_SENSOR_SCORE": 0.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 7.0 }, "treatments": [] }, "TCGA-DI-A2QU": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "E9FA66F5-282C-416A-9DCF-46714EA12FCF", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24488.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 31.10102903, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 31.10102903, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 31.10102903, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DI-A2QU-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3052, "MSI_SENSOR_SCORE": 0.3, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 196.0 }, "treatments": [] }, "TCGA-D1-A17L": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "67ccb182-3021-4621-bffb-6565574dbc58", "AGE": 81.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "802", "DAYS_TO_BIRTH": -29899.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 123.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 26.36683434, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 26.36683434, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 26.36683434, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 26.36683434, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17L-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2703, "MSI_SENSOR_SCORE": 0.21, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.1, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-B5-A0JS": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0da7bbd4-ed8d-474b-b494-cb93c5fa811e", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2627", "DAYS_TO_BIRTH": -19995.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 110.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.36617681, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.36617681, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 86.36617681, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 86.36617681, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0JS-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2933, "MSI_SENSOR_SCORE": 0.03, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-AW-A1PO": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4cb4dd07-0ce5-4de7-a0bd-546183949efe", "AGE": 66.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "17", "DAYS_TO_BIRTH": -24225.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 0.558897985, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 0.558897985, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 0.558897985, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AW-A1PO-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AW", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3268, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.266666667, "TISSUE_SOURCE_SITE": "Cureline", "TBL_SCORE": 106.0 }, "treatments": [] }, "TCGA-AX-A05U": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e56c6abc-b36c-4667-a347-0a541ce4791d", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "903", "DAYS_TO_BIRTH": -20533.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "American Indian or Alaska Native", "RADIATION_THERAPY": "No", "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.68734589, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.68734589, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.68734589, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.68734589, "GENETIC_ANCESTRY_LABEL": "AMR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A05U-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2546, "MSI_SENSOR_SCORE": 0.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.9, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 10.0 }, "treatments": [] }, "TCGA-AP-A0LP": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "efae3940-d3cc-4988-bdb4-fa05d977aff5", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1875", "DAYS_TO_BIRTH": -27898.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 61.64316008, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 61.64316008, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 61.64316008, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 61.64316008, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LP-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5949, "MSI_SENSOR_SCORE": 17.64, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.9, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 57, "STOP_DATE": 391.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Megestrol Acetate", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 53440.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 79, "STOP_DATE": 113.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 114, "STOP_DATE": 118.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 540.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0GN": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "a2a2dbda-d10c-49c4-86a8-61baf6160cda", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1841", "DAYS_TO_BIRTH": -24020.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/13/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 60.52536411, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 60.52536411, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 60.52536411, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 60.52536411, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GN-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2642, "MSI_SENSOR_SCORE": 0.65, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 5.0 }, "treatments": [ { "START_DATE": 71, "STOP_DATE": 112.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A17S": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "24434832-46fc-485a-9ff4-2aa95c3d3936", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "739", "DAYS_TO_BIRTH": -21794.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 109.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 24.29562416, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 24.29562416, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 24.29562416, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 24.29562416, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17S-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.265, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BG-A0M2": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9731e0b3-c62d-43cb-8ae7-8f973d69ab19", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "637", "DAYS_TO_BIRTH": -22822.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/1/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.94223625, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.94223625, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.94223625, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.94223625, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0M2-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 10.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2688, "MSI_SENSOR_SCORE": 0.83, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.933333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-DI-A1NN": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "944a102f-3475-45aa-9e30-4b92d1449f00", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1076", "DAYS_TO_BIRTH": -23026.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "8/1/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.3749548, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.3749548, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 33.63250814, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 33.63250814, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-DI-A1NN-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "DI", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3003, "MSI_SENSOR_SCORE": 0.17, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "MD Anderson", "TBL_SCORE": 163.0 }, "treatments": [ { "START_DATE": 44, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "3070", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3070.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 44, "STOP_DATE": 147.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "1915", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1915.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1045, "STOP_DATE": 1121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Selumetinib", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "150", "PRESCRIBED_DOSE_UNITS": "mg/day", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 600.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A161": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0305db4a-62ee-4ecb-bede-032981298732", "AGE": 78.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "892", "DAYS_TO_BIRTH": -28695.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.32570602, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.32570602, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.32570602, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.32570602, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A161-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2671, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.633333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 12.0 }, "treatments": [] }, "TCGA-B5-A0K1": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "40a3ed98-3892-449c-b07e-7b7612bd997e", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1110", "DAYS_TO_BIRTH": -25291.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/5/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 117.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 36.49275076, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 36.49275076, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 36.49275076, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 36.49275076, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0K1-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2459, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.4, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-AJ-A3EL": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "23E1D96E-6175-4145-8267-8F0A88F54C4D", "AGE": 47.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "684", "DAYS_TO_BIRTH": -17442.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Native Hawaiian or Other Pacific Islander", "RADIATION_THERAPY": "No", "WEIGHT": 57.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.4874248, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.4874248, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.4874248, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.4874248, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3EL-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.298, "MSI_SENSOR_SCORE": 1.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 248.3333333, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 21.0 }, "treatments": [] }, "TCGA-EY-A1GK": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "972db411-9744-46f0-89c7-efe14135f1b4", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "693", "DAYS_TO_BIRTH": -27127.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 105.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 22.78331196, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 22.78331196, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 22.78331196, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 22.78331196, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GK-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9016, "MSI_SENSOR_SCORE": 21.97, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 28.23333333, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 107, "STOP_DATE": 121.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A1GF": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "615ea37d-6302-4d68-b253-d24efd947c3e", "AGE": 75.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "826", "DAYS_TO_BIRTH": -27450.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.15586679, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.15586679, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.15586679, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.15586679, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GF-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7116, "MSI_SENSOR_SCORE": 16.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.3, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-A5-A0G5": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4806d9a6-e65d-4a82-b422-1b287980a0c6", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1126", "DAYS_TO_BIRTH": -26827.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/13/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8310/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 48.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 37.0187724, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 37.0187724, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 37.0187724, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 37.0187724, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0G5-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 14.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2625, "MSI_SENSOR_SCORE": 0.66, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.133333333, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 770.0 }, "treatments": [ { "START_DATE": 115, "STOP_DATE": 882.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 889, "STOP_DATE": 898.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 10.0, "RADIATION_DOSAGE": 1260.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A063": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e8909bdf-460c-4291-8e9b-7be12f343eae", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2417", "DAYS_TO_BIRTH": -23045.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/24/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 88.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 79.46214288, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 79.46214288, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 79.46214288, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 79.46214288, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A063-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.922, "MSI_SENSOR_SCORE": 34.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 33.56666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-AP-A05P": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "3cb83517-78a4-47b8-8b1e-57e765dbdd2e", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "636", "DAYS_TO_BIRTH": -20017.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 20.9093599, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 20.9093599, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 20.9093599, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 20.9093599, "GENETIC_ANCESTRY_LABEL": "SAS" }, "sample": { "SAMPLE_ID": "TCGA-AP-A05P-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2436, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.666666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-AJ-A8CV": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4557D1FB-9786-4780-BD33-02E9DA04B7E3", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1068", "DAYS_TO_BIRTH": -21336.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/27/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 86.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.11194398, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.11194398, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.11194398, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.11194398, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A8CV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5694, "MSI_SENSOR_SCORE": 7.86, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.266666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BK-A139": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8d9e4917-334b-4c76-aee1-1e22be772db0", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "309", "DAYS_TO_BIRTH": -27077.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 31.00239997, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 31.00239997, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 22.4874248, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BK-A139-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 25.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2959, "MSI_SENSOR_SCORE": 0.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 4.2, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 267.0 }, "treatments": [] }, "TCGA-2E-A9G8": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9583C10B-B21A-4863-98FA-61E735E64EA5", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1249", "DAYS_TO_BIRTH": null, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/21/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.3", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.3", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 41.0625637, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 41.0625637, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 11.01357793, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-2E-A9G8-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "2E", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3234, "MSI_SENSOR_SCORE": 0.85, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.166666667, "TISSUE_SOURCE_SITE": "University of Kansas Medical Center", "TBL_SCORE": 236.0 }, "treatments": [ { "START_DATE": 488, "STOP_DATE": 580.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 488, "STOP_DATE": 610.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 122, "STOP_DATE": 122.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 4.0, "RADIATION_DOSAGE": 2200.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 427, "STOP_DATE": 457.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 5000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A3FX": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6F45A2E9-1CA5-438C-B06F-1CD8EB845465", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "4", "DAYS_TO_BIRTH": -25260.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/3/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 85.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 43.82417727, "DSS_STATUS": null, "DSS_MONTHS": 43.82417727, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 30.83801821, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3FX-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2922, "MSI_SENSOR_SCORE": 0.11, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 483.0 }, "treatments": [ { "START_DATE": 939, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin + Paclitaxel + Bevacizumab", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1255, "STOP_DATE": 1336.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Not Specified", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin + Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A3KX": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "FE2E89F7-8F4D-420A-A551-4877CF0FD1D3", "AGE": 80.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1170", "DAYS_TO_BIRTH": -29260.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "6/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 44.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 38.46533189, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 38.46533189, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 38.46533189, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 38.46533189, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-EO-A3KX-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.2214, "MSI_SENSOR_SCORE": 35.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 107.6, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-AP-A056": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "585a1f31-3804-43ca-81e9-4e571fe03642", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "2618", "DAYS_TO_BIRTH": -23707.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 56.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 86.07028964, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 86.07028964, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 86.07028964, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 86.07028964, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A056-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2881, "MSI_SENSOR_SCORE": 1.71, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 275.4, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 33.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 126.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A3JQ": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "07C805C2-FF09-4D5A-95F8-1D7D9F84C33C", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "526", "DAYS_TO_BIRTH": -22297.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/19/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 121.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.29296117, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.29296117, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.29296117, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.29296117, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A3JQ-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 4.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3422, "MSI_SENSOR_SCORE": 0.09, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.0, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 202.0 }, "treatments": [ { "START_DATE": 68, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 67, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 67, "STOP_DATE": 173.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 200, "STOP_DATE": 237.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 28.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A05A": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "c350b53b-3c27-4b9e-8b57-d7b6a1205a1f", "AGE": 81.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1199", "DAYS_TO_BIRTH": -29914.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 63.91162837, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 63.91162837, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 63.91162837, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 63.91162837, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A05A-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2515, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.333333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 295.0 }, "treatments": [ { "START_DATE": 94, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Hormone Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Anastrazole", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": "1", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "PO", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 116, "STOP_DATE": 137.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1800.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0U9": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5ffa2ec6-2d94-4b09-8fb9-3591cf38fa4f", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2825", "DAYS_TO_BIRTH": -21580.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Native Hawaiian or Other Pacific Islander", "RADIATION_THERAPY": "No", "WEIGHT": 99.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 92.87569451, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 92.87569451, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 92.87569451, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 92.87569451, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0U9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": null, "MSI_SENSOR_SCORE": 0.49, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.2, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 191.0 }, "treatments": [] }, "TCGA-D1-A16S": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "0b670df6-c487-4ed6-9b48-ef4b01a1aec3", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "568", "DAYS_TO_BIRTH": -25690.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 59.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.67376796, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.67376796, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 18.67376796, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.67376796, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16S-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 19.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2503, "MSI_SENSOR_SCORE": 0.86, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 329.0 }, "treatments": [] }, "TCGA-AJ-A3NF": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9FCBEF9E-2CCA-4033-B574-DAAB2A42198B", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "645", "DAYS_TO_BIRTH": -22210.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/17/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 117.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 21.20524707, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 21.20524707, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 21.20524707, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 21.20524707, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3NF-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 12.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2883, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.833333333, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 246.0 }, "treatments": [ { "START_DATE": 192, "STOP_DATE": 253.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Nos", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 158, "STOP_DATE": 193.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 192, "STOP_DATE": 222.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A2AE": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f384eb3f-92ab-4327-87eb-45b5f72a1580", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "721", "DAYS_TO_BIRTH": -21069.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 135.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.70384982, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.70384982, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.70384982, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.70384982, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A2AE-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 6.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3042, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 3.666666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 17.0 }, "treatments": [ { "START_DATE": 99, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 99, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 120, "STOP_DATE": 209.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 230, "STOP_DATE": 273.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-E6-A2P8": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "D213DA3A-FF1C-4FBD-8D4E-7F9E6A2318D0", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -19448.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 2.367097347, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 2.367097347, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 1.972581122, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-E6-A2P8-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "E6", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6942, "MSI_SENSOR_SCORE": 17.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 18.8, "TISSUE_SOURCE_SITE": "Roswell Park", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-A5-A0GX": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "553f0ccd-4e6f-4ae2-9b39-97529eb3d826", "AGE": 53.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "2088", "DAYS_TO_BIRTH": -19625.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/13/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 108.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 68.64582306, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 68.64582306, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 68.64582306, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 68.64582306, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GX-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2715, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 3.0 }, "treatments": [ { "START_DATE": 167, "STOP_DATE": 213.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 31.0, "RADIATION_DOSAGE": 5580.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A2CG": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "AF363CEC-BEC9-4DE3-8CC2-E98B0EED2858", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1564", "DAYS_TO_BIRTH": -25279.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/26/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 51.41861459, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 51.41861459, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 51.41861459, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 51.41861459, "GENETIC_ANCESTRY_LABEL": "ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-EO-A2CG-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 24.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2776, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.166666667, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 397.0 }, "treatments": [ { "START_DATE": 114, "STOP_DATE": 243.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 114, "STOP_DATE": 243.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 285, "STOP_DATE": 319.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EY-A548": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "56BDB68C-A647-4ABA-94AC-9CD52BB5344A", "AGE": 83.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "430", "DAYS_TO_BIRTH": -30544.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/27/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 67.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 14.13683138, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 14.13683138, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 14.13683138, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 14.13683138, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A548-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8116, "MSI_SENSOR_SCORE": 17.93, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 20.0, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-AJ-A3NH": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7186180A-688A-4FCC-9A67-166EFF032E4B", "AGE": 90.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "23", "DAYS_TO_BIRTH": -32871.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/17/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 65.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 10.19166913, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.19166913, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.19166913, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.19166913, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3NH-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 27.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3145, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 224.0 }, "treatments": [ { "START_DATE": 66, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 66, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-PG-A916": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5EDAED6D-9914-4DF2-A843-D6009C36CBCC", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "522", "DAYS_TO_BIRTH": -25617.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/28/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": null, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 17.16145577, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 17.16145577, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 17.16145577, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 17.16145577, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-PG-A916-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "PG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3407, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "Montefiore Medical Center", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-BG-A0M9": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4fd1cb59-6c50-4355-9d37-a341e1f4fad9", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2270", "DAYS_TO_BIRTH": -26708.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "12/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 74.62931913, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 74.62931913, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 74.62931913, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 74.62931913, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0M9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2818, "MSI_SENSOR_SCORE": 0.16, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.933333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-A5-A0GW": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5b6b9d0f-787c-4ae9-afd4-de7ce6c57a42", "AGE": 46.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "706", "DAYS_TO_BIRTH": -17092.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/27/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "Yes", "WEIGHT": 49.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 23.21070454, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 23.21070454, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 23.21070454, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 23.21070454, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GW-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6829, "MSI_SENSOR_SCORE": 24.38, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 10.26666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 7.0 }, "treatments": [ { "START_DATE": 106, "STOP_DATE": 120.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1800.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A0ZP": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ac216bb5-15e4-4462-955e-8a522380690e", "AGE": 59.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "911", "DAYS_TO_BIRTH": -21581.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.95035671, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.95035671, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 20.67922543, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A0ZP-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2709, "MSI_SENSOR_SCORE": 0.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 146.0 }, "treatments": [ { "START_DATE": 26, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1680.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 26, "STOP_DATE": 134.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "5", "PRESCRIBED_DOSE_UNITS": "auc", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 4180.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 818, "STOP_DATE": 861.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "45", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 220.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 818, "STOP_DATE": 861.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 3.0, "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "Yes", "TOTAL_DOSE": 780.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 725, "STOP_DATE": 757.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 5000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0UF": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f77d7256-2ccf-42a7-9b30-332ac24ca812", "AGE": 65.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2611", "DAYS_TO_BIRTH": -23771.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 57.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 85.84015518, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 85.84015518, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 85.84015518, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 85.84015518, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0UF-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3009, "MSI_SENSOR_SCORE": 0.93, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 280.4333333, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-A5-A0GQ": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "c8d672ed-9910-4f80-b222-38c833f55850", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2247", "DAYS_TO_BIRTH": -28078.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "1/7/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 57.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 73.87316303, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 73.87316303, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 73.87316303, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 73.87316303, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GQ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.261, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.9, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-EO-A3B0": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4C2E6ABF-02E1-4EF7-A0BE-6A6D4069581D", "AGE": 43.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1412", "DAYS_TO_BIRTH": -15954.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 53.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 46.42140908, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 46.42140908, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 46.42140908, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-EO-A3B0-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3052, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 366.8666667, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-5B-A90C": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "16AC4341-CF8F-45E2-B90B-2D12D5F74A59", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1202", "DAYS_TO_BIRTH": -25518.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/17/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 98.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 39.51737515, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 39.51737515, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 16.99707401, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-5B-A90C-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "5B", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3344, "MSI_SENSOR_SCORE": 0.55, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.566666667, "TISSUE_SOURCE_SITE": "Medical College of Wisconsin", "TBL_SCORE": 469.0 }, "treatments": [ { "START_DATE": 682, "STOP_DATE": 883.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 682, "STOP_DATE": 883.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 67, "STOP_DATE": 82.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 6000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A11P": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "d1c65e6a-098e-4c10-9183-c303ba66015a", "AGE": 87.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1583", "DAYS_TO_BIRTH": -32047.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "8/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 52.04326528, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 52.04326528, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 52.04326528, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A11P-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 20.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3046, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.466666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-D1-A17Q": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "ca8dbbfd-8928-4e25-94c6-b875de631bbd", "AGE": 54.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "54", "DAYS_TO_BIRTH": -20015.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 68.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.77532301, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.77532301, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 1.77532301, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.77532301, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17Q-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2907, "MSI_SENSOR_SCORE": 0.78, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 198.9666667, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-D1-A17M": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "02b2cd50-221f-437c-a1ce-6da1467ec809", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "311", "DAYS_TO_BIRTH": -20685.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 142.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 10.22454548, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 10.22454548, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 10.22454548, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 10.22454548, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17M-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.53, "MSI_SENSOR_SCORE": 16.57, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.53333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 84, "STOP_DATE": 90.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1989.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AP-A1E3": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "44ac7093-a733-4c55-a964-0ba9ec141d2d", "AGE": 45.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "847", "DAYS_TO_BIRTH": -16544.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 130.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.84627018, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.84627018, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.84627018, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1E3-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2838, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.366666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 96, "STOP_DATE": 320.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 10.0, "PRESCRIBED_DOSE": "45", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1000.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 97, "STOP_DATE": 321.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 10.0, "PRESCRIBED_DOSE": "160", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3500.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EO-A3AS": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2C3E95B5-2C63-43C7-BAA2-47EF914B25A8", "AGE": 86.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1046", "DAYS_TO_BIRTH": -31450.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/1/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": null, "RADIATION_THERAPY": "No", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.38866423, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.38866423, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 34.38866423, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.38866423, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EO-A3AS-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": null, "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EO", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 5.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3139, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.266666667, "TISSUE_SOURCE_SITE": "University Health Network", "TBL_SCORE": 209.0 }, "treatments": [] }, "TCGA-D1-A16F": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "60c65e5e-57a4-4f15-8b95-30bd2dbd9010", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "80", "DAYS_TO_BIRTH": -22242.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 90.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 2.630108163, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 2.630108163, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 2.630108163, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 2.630108163, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A16F-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6303, "MSI_SENSOR_SCORE": 21.79, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 16.43333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": null }, "treatments": [] }, "TCGA-D1-A17B": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e55dd65a-c75e-4a3c-bb24-8b3af4d65321", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "213", "DAYS_TO_BIRTH": -25504.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/14/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 110.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 7.002662985, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 7.002662985, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 7.002662985, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 7.002662985, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A17B-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.436, "MSI_SENSOR_SCORE": 8.2, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 9.633333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-BG-A0W2": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "f47df5f9-7c60-4b1a-b574-7036245af341", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1721", "DAYS_TO_BIRTH": -20998.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 121.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 56.58020186, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 56.58020186, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 56.58020186, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 56.58020186, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A0W2-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2844, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.066666667, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-EY-A5W2": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "1944E155-B765-48C3-9602-6787C105E551", "AGE": 72.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "516", "DAYS_TO_BIRTH": -26498.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/20/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 83.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.96419765, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.96419765, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.96419765, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.96419765, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-EY-A5W2-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9861, "MSI_SENSOR_SCORE": 27.19, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 26.06666667, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 70, "STOP_DATE": 77.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BK-A0CC": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2b865f8c-539f-4cb2-8f08-41709e9511e5", "AGE": 69.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1067", "DAYS_TO_BIRTH": -25479.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/8/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.07906763, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.07906763, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 33.20511556, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 33.20511556, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-BK-A0CC-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3195, "MSI_SENSOR_SCORE": 5.36, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.766666667, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 168.7 }, "treatments": [ { "START_DATE": 59, "STOP_DATE": 289.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "362-503", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2592.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 59, "STOP_DATE": 289.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 12.0, "PRESCRIBED_DOSE": "100-3001", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1795.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 147, "STOP_DATE": 179.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3QS": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "69FC74BC-E961-40E2-9169-D7B51658EB10", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "513", "DAYS_TO_BIRTH": -21162.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/28/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 71.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.8655686, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.8655686, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.8655686, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.8655686, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3QS-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 16.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2803, "MSI_SENSOR_SCORE": 0.22, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 7.6, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 310.0 }, "treatments": [ { "START_DATE": 114, "STOP_DATE": 174.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 114, "STOP_DATE": 143.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 148, "STOP_DATE": 162.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-EC-A24G": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "b5c1e511-baf2-45b3-9919-110e8941e3c2", "AGE": 57.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "511", "DAYS_TO_BIRTH": -20857.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/21/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 16.79981589, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 16.79981589, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 16.79981589, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 16.79981589, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-EC-A24G-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EC", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5199, "MSI_SENSOR_SCORE": 6.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 34.2, "TISSUE_SOURCE_SITE": "Asterand", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 47, "STOP_DATE": 257.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": 1.0, "PRESCRIBED_DOSE": "1200", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1200.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 47, "STOP_DATE": 257.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "80", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 480.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 47, "STOP_DATE": 257.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 4.0, "PRESCRIBED_DOSE": "540", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 2160.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 47, "STOP_DATE": 257.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cyclophosphamide", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": "1600", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 8000.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 47, "STOP_DATE": 257.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 2.0, "PRESCRIBED_DOSE": "550", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1100.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 76, "STOP_DATE": 107.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 20.0, "RADIATION_DOSAGE": 4000.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A3EJ": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "672DE064-3378-4004-A3EA-F79885E10D78", "AGE": 74.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -27317.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/15/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 73.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 1.643817602, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 1.643817602, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 1.643817602, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A3EJ-01", "ONCOTREE_CODE": "UMEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Mixed Endometrial Carcinoma", "TUMOR_TYPE": "Mixed Serous and Endometrioid Carcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2933, "MSI_SENSOR_SCORE": 0.29, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.866666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 262.0 }, "treatments": [] }, "TCGA-AP-A3K1": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "211B2C52-1AD8-4D33-AF0B-69EC1A56C821", "AGE": 56.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "555", "DAYS_TO_BIRTH": -20594.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/16/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 21.89565046, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 21.89565046, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 6.509517704, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A3K1-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 26.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3224, "MSI_SENSOR_SCORE": 1.07, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.0, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 121.0 }, "treatments": [ { "START_DATE": 74, "STOP_DATE": 94.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 74, "STOP_DATE": 94.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "stable disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 144, "STOP_DATE": 186.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 218, "STOP_DATE": 267.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 218, "STOP_DATE": 267.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "clinical progressive disease", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A2K3": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "C3096984-BD11-44A0-8EE0-47F07AD04D81", "AGE": 68.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "2012", "DAYS_TO_BIRTH": -24907.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/4/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.1472203, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.1472203, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 66.1472203, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.1472203, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A2K3-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 18.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4541, "MSI_SENSOR_SCORE": 1.65, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 41.1, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 13.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "175", "PRESCRIBED_DOSE_UNITS": "mg/m2", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 1908.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 58, "STOP_DATE": 161.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "3978", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3978.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A0K6": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5cba9441-6812-49c0-a0f6-7928ed4e5b81", "AGE": 58.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1953", "DAYS_TO_BIRTH": -21515.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "1/19/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 132.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 64.20751553, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 64.20751553, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 64.20751553, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 64.20751553, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A0K6-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.5327, "MSI_SENSOR_SCORE": 16.83, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 11.76666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-AX-A3G9": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "F7527B5E-5330-49EA-82CE-F6F2CDCCBADC", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "558", "DAYS_TO_BIRTH": -23361.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "2/7/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 60.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 18.34500444, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 18.34500444, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 18.34500444, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3G9-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 1.016, "MSI_SENSOR_SCORE": 25.12, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.96666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 1.0 }, "treatments": [ { "START_DATE": 125, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin + Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A0G3": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "8432401d-799f-4f2f-b536-e79e1e8be064", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "1428", "DAYS_TO_BIRTH": -22421.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 46.94743071, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 46.94743071, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 26.13669987, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 26.13669987, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0G3-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.272, "MSI_SENSOR_SCORE": 1.18, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.266666667, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 536.0 }, "treatments": [ { "START_DATE": 487, "STOP_DATE": 596.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "500", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 2.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 3000.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 487, "STOP_DATE": 596.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Docetaxel", "NUMBER_OF_CYCLES": 6.0, "PRESCRIBED_DOSE": "90-100", "PRESCRIBED_DOSE_UNITS": "mg", "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": "IV", "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": 590.0, "TOTAL_DOSE_UNITS": "mg", "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 60, "STOP_DATE": 97.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 27.0, "RADIATION_DOSAGE": 4860.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 112, "STOP_DATE": 132.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1079, "STOP_DATE": 1079.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 3", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 1.0, "RADIATION_DOSAGE": 7900.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 1163, "STOP_DATE": 1163.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 4", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Progression", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Distant Recurrence", "COURSE_NUMBER": 3.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 6900.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A160": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "170bbbac-940f-4e1b-b0b8-60fa36d0fa23", "AGE": 70.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "112", "DAYS_TO_BIRTH": -25673.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 122.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 3.682151429, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 3.682151429, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 3.682151429, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 3.682151429, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A160-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6785, "MSI_SENSOR_SCORE": 21.45, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 16.73333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-AJ-A2QM": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "D9F4A2C1-AC6D-48C6-95FE-FFBC2FA08268", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "894", "DAYS_TO_BIRTH": -24776.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.39145872, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.39145872, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.39145872, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.39145872, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A2QM-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 11.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3159, "MSI_SENSOR_SCORE": 0.37, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 6.066666667, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 229.0 }, "treatments": [ { "START_DATE": 46, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 46, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 172, "STOP_DATE": 184.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": 1500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 128, "STOP_DATE": 163.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 25.0, "RADIATION_DOSAGE": 4500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BS-A0WQ": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "e095a927-d985-4fbd-8093-46c1c6ace4de", "AGE": 55.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2022", "DAYS_TO_BIRTH": -20131.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/25/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Asian", "RADIATION_THERAPY": "No", "WEIGHT": 93.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 66.47598383, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 66.47598383, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 66.47598383, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 66.47598383, "GENETIC_ANCESTRY_LABEL": "EAS" }, "sample": { "SAMPLE_ID": "TCGA-BS-A0WQ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BS", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2671, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.433333333, "TISSUE_SOURCE_SITE": "University of Hawaii", "TBL_SCORE": 5.0 }, "treatments": [] }, "TCGA-EY-A3L3": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "06728B1B-6B69-4467-8E10-A8A4E6328AC8", "AGE": 82.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "832", "DAYS_TO_BIRTH": -30138.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/23/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 92.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 27.3531249, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 27.3531249, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 27.3531249, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 27.3531249, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-EY-A3L3-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 15.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2962, "MSI_SENSOR_SCORE": 0.94, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 351.0 }, "treatments": [ { "START_DATE": 119, "STOP_DATE": 231.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 119, "STOP_DATE": 231.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 198, "STOP_DATE": 198.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A2H4": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "AFA79B18-2AC6-4179-9C8C-5FA4D1D09A7E", "AGE": 66.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": null, "DAYS_TO_BIRTH": -24234.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/28/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "Yes", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "1:DECEASED", "OS_MONTHS": 30.11473847, "DSS_STATUS": "1:DEAD WITH TUMOR", "DSS_MONTHS": 30.11473847, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 17.09570306, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 17.09570306, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A2H4-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 21.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3093, "MSI_SENSOR_SCORE": 0.35, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 5.6, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 719.0 }, "treatments": [] }, "TCGA-EY-A1GD": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "33efe6c6-9159-48e8-b759-fba9ddbde761", "AGE": 51.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1639", "DAYS_TO_BIRTH": -18638.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/2/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 79.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 53.88434099, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 53.88434099, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 53.88434099, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 53.88434099, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-EY-A1GD-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "EY", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2816, "MSI_SENSOR_SCORE": 0.1, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 36.1, "TISSUE_SOURCE_SITE": "University of North Carolina", "TBL_SCORE": 1.0 }, "treatments": [] }, "TCGA-AP-A0LS": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "c5a797d3-82ae-49dc-b2fe-0da64da271a2", "AGE": 63.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "2904", "DAYS_TO_BIRTH": -23126.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "6/22/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 81.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 95.47292632, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 95.47292632, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 95.47292632, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 95.47292632, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LS-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8371, "MSI_SENSOR_SCORE": 14.91, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 14.0, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 78, "STOP_DATE": 98.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AJ-A2QL": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "9002FC6C-26DE-4B8F-8985-A4814CD3DAF7", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "602", "DAYS_TO_BIRTH": -22057.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "10/18/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "With Tumor", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 112.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.79156393, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.79156393, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.79156393, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.79156393, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AJ-A2QL-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "AJ", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.3116, "MSI_SENSOR_SCORE": 0.01, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 2.8, "TISSUE_SOURCE_SITE": "International Genomics Conosrtium", "TBL_SCORE": 2.0 }, "treatments": [ { "START_DATE": 110, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Cisplatin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 110, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Doxorubicin", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 110, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "No", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A1CE": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "4db38349-28d2-4af5-a12f-3d861937b0e0", "AGE": 60.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1037", "DAYS_TO_BIRTH": -21969.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/11/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 58.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 34.09277707, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 34.09277707, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 34.09277707, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A1CE-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.6541, "MSI_SENSOR_SCORE": 17.4, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 383.8666667, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 25.0 }, "treatments": [ { "START_DATE": 35, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-AX-A0IU": { "demographics": { "SUBTYPE": "UCEC_CN_HIGH", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "7e64ea6c-a3db-48eb-91be-131361510a92", "AGE": 79.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1087", "DAYS_TO_BIRTH": -29063.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/23/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": null, "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 35.73659467, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 35.73659467, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 35.73659467, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 35.73659467, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A0IU-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 9.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.289, "MSI_SENSOR_SCORE": 0.25, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.8, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 240.0 }, "treatments": [ { "START_DATE": 64, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Carboplatin", "NUMBER_OF_CYCLES": 5.0, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": 1.0, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 64, "STOP_DATE": null, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Chemotherapy", "TREATMENT_SUBTYPE": null, "AGENT": "Paclitaxel", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": "adjuvent", "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": "No", "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": "Yes", "ANATOMIC_TREATMENT_SITE": null, "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": null, "RADIATION_DOSAGE": null, "RADIATION_TREATMENT_ONGOING": null, "RADIATION_TYPE": null, "RADIATION_UNITS": null, "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BG-A186": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "fe4db898-3a9f-4dff-adcb-7b8c30137350", "AGE": 61.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "419", "DAYS_TO_BIRTH": -22370.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "5/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 75.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.77519151, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.77519151, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.77519151, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.77519151, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-BG-A186-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "BG", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2865, "MSI_SENSOR_SCORE": 0.08, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.033333333, "TISSUE_SOURCE_SITE": "University of Pittsburgh", "TBL_SCORE": 2.0 }, "treatments": [] }, "TCGA-A5-A0GV": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5e3b981e-73fe-4cc9-8c89-b420e8e2f426", "AGE": 67.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "1643", "DAYS_TO_BIRTH": -24540.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "9/10/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 63.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 54.0158464, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 54.0158464, "DFS_STATUS": "1:Recurred/Progressed", "DFS_MONTHS": 9.99441102, "PFS_STATUS": "1:PROGRESSION", "PFS_MONTHS": 9.99441102, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A0GV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 7.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.263, "MSI_SENSOR_SCORE": 0.14, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.533333333, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 6.0 }, "treatments": [ { "START_DATE": 390, "STOP_DATE": 426.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 6.0, "RADIATION_DOSAGE": 5040.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "External Beam", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null }, { "START_DATE": 448, "STOP_DATE": 461.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 2", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Recurrence", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 2.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 1500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Implants", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-BK-A56F": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "2D166DC0-8890-4B00-AB73-9E2DBB6C530D", "AGE": 75.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "401", "DAYS_TO_BIRTH": -27523.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/2/2013", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "Yes", "WEIGHT": 84.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 13.18341717, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 13.18341717, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 13.18341717, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 13.18341717, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-BK-A56F-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "BK", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.297, "MSI_SENSOR_SCORE": 0.0, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.833333333, "TISSUE_SOURCE_SITE": "Christiana Healthcare", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 126, "STOP_DATE": 140.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": null, "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": "complete response", "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": null, "NUMBER_OF_FRACTIONS": 5.0, "RADIATION_DOSAGE": 3500.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Internal", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-D1-A0ZO": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "b3d635b3-d7ac-4cf8-a318-0a9dd0073e89", "AGE": 75.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "602", "DAYS_TO_BIRTH": -27482.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "3/4/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "Yes", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 110.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 19.79156393, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 19.79156393, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 19.79156393, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 19.79156393, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A0ZO-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7496, "MSI_SENSOR_SCORE": 28.32, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 21.03333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-AP-A0LJ": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "b4a520ae-f259-48c8-823e-c10b9b8a133a", "AGE": 42.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "1421", "DAYS_TO_BIRTH": -15577.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 80.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 46.71729625, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 46.71729625, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 46.71729625, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 46.71729625, "GENETIC_ANCESTRY_LABEL": " " }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 2.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2669, "MSI_SENSOR_SCORE": 0.02, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 1.233333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 3.0 }, "treatments": [] }, "TCGA-AP-A0LV": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "5dfdfcfc-72cc-4e33-aa3f-0d744eb94330", "AGE": 39.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": null, "DAYS_LAST_FOLLOWUP": "763", "DAYS_TO_BIRTH": -14556.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "9/23/2010", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 76.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 25.08465661, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 25.08465661, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 25.08465661, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 25.08465661, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-AP-A0LV-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G1", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.2684, "MSI_SENSOR_SCORE": 0.06, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 0.666666667, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 0.0 }, "treatments": [] }, "TCGA-D1-A15X": { "demographics": { "SUBTYPE": "UCEC_CN_LOW", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "14c03068-8930-472a-9fd1-49c9fd4db47d", "AGE": 45.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1995.0, "DAYS_LAST_FOLLOWUP": "909", "DAYS_TO_BIRTH": -16532.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/13/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8441/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "Yes", "WEIGHT": 72.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 29.884604, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 29.884604, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 29.884604, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 29.884604, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-D1-A15X-01", "ONCOTREE_CODE": "USC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma", "TUMOR_TYPE": "Serous Endometrial Adenocarcinoma", "GRADE": "High Grade", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "D1", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4476, "MSI_SENSOR_SCORE": 11.04, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 50.53333333, "TISSUE_SOURCE_SITE": "Mayo Clinic", "TBL_SCORE": 4.0 }, "treatments": [ { "START_DATE": 43, "STOP_DATE": 58.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Regional Site", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-B5-A3FA": { "demographics": { "SUBTYPE": "UCEC_POLE", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "AC9EC63A-C3B6-4D0C-B1A9-7C72DBAD456C", "AGE": 73.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "2929", "DAYS_TO_BIRTH": -26850.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "3/19/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 74.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 96.29483513, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 96.29483513, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 96.29483513, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-B5-A3FA-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "B5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.4634, "MSI_SENSOR_SCORE": 7.28, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 324.0666667, "TISSUE_SOURCE_SITE": "Duke", "TBL_SCORE": 8.0 }, "treatments": [] }, "TCGA-AP-A1DH": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "07d1aef3-31c7-4c44-a078-16a9eb096d58", "AGE": 62.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "2180", "DAYS_TO_BIRTH": -22652.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "5/9/2011", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": "No", "WEIGHT": 127.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 71.67044745, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 71.67044745, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 71.67044745, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 71.67044745, "GENETIC_ANCESTRY_LABEL": "AFR_ADMIX" }, "sample": { "SAMPLE_ID": "TCGA-AP-A1DH-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AP", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 0.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.7077, "MSI_SENSOR_SCORE": 13.83, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 19.43333333, "TISSUE_SOURCE_SITE": "MSKCC", "TBL_SCORE": 0.0 }, "treatments": [ { "START_DATE": 58, "STOP_DATE": 86.0, "EVENT_TYPE": "Treatment", "TREATMENT_TYPE": "Radiation Therapy", "TREATMENT_SUBTYPE": null, "AGENT": "Radiation 1", "NUMBER_OF_CYCLES": null, "PRESCRIBED_DOSE": null, "PRESCRIBED_DOSE_UNITS": null, "REGIMEN_NUMBER": null, "REGIMEN_INDICATION": "Adjuvant", "REGIMEN_INDICATION_NOTES": null, "MEASURE_OF_RESPONSE": null, "CLINICAL_TRIAL_DRUG_CLASSIFICATION": null, "ROUTE_OF_ADMINISTRATION": null, "ROUTE_OF_ADMINISTRATION-2": null, "THERAPY_ONGOING": null, "TOTAL_DOSE": null, "TOTAL_DOSE_UNITS": null, "TX_ON_CLINICAL_TRIAL": null, "ANATOMIC_TREATMENT_SITE": "Primary Tumor Field", "COURSE_NUMBER": 1.0, "NUMBER_OF_FRACTIONS": 3.0, "RADIATION_DOSAGE": 2100.0, "RADIATION_TREATMENT_ONGOING": "No", "RADIATION_TYPE": "Other", "RADIATION_UNITS": "cgy", "PHARM_REGIMEN": null, "STEM_CELL_TRANSPLANTATION": null, "STEM_CELL_TRANSPLANTATION_TYPE": null } ] }, "TCGA-A5-A7WJ": { "demographics": { "SUBTYPE": null, "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "A3E728CE-0874-4F4B-A83D-8C679F4BD938", "AGE": 64.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 2009.0, "DAYS_LAST_FOLLOWUP": "341", "DAYS_TO_BIRTH": -23723.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": "Not Hispanic Or Latino", "FORM_COMPLETION_DATE": "4/22/2014", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": "No", "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": "Tumor Free", "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "Black or African American", "RADIATION_THERAPY": "No", "WEIGHT": 64.0, "IN_PANCANPATHWAYS_FREEZE": "No", "OS_STATUS": "0:LIVING", "OS_MONTHS": 11.21083605, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 11.21083605, "DFS_STATUS": "0:DiseaseFree", "DFS_MONTHS": 11.21083605, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 11.21083605, "GENETIC_ANCESTRY_LABEL": "AFR" }, "sample": { "SAMPLE_ID": "TCGA-A5-A7WJ-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G2", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_SOURCE_SITE_CODE": "A5", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": null, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.8862, "MSI_SENSOR_SCORE": 22.73, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": null, "TISSUE_SOURCE_SITE": "Cedars Sinai", "TBL_SCORE": 4.0 }, "treatments": [] }, "TCGA-AX-A3G8": { "demographics": { "SUBTYPE": "UCEC_MSI", "CANCER_TYPE_ACRONYM": "UCEC", "OTHER_PATIENT_ID": "6D3FDB58-FDC0-4937-AD38-3A455225EA51", "AGE": 76.0, "SEX": "Female", "AJCC_PATHOLOGIC_TUMOR_STAGE": null, "AJCC_STAGING_EDITION": 1988.0, "DAYS_LAST_FOLLOWUP": "30", "DAYS_TO_BIRTH": -27899.0, "DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS": 0.0, "ETHNICITY": null, "FORM_COMPLETION_DATE": "2/7/2012", "HISTORY_NEOADJUVANT_TRTYN": "No", "ICD_10": "C54.1", "ICD_O_3_HISTOLOGY": "8380/3", "ICD_O_3_SITE": "C54.1", "INFORMED_CONSENT_VERIFIED": "Yes", "NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT": null, "PATH_M_STAGE": null, "PATH_N_STAGE": null, "PATH_T_STAGE": null, "PERSON_NEOPLASM_CANCER_STATUS": null, "PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT": null, "PRIOR_DX": "No", "RACE": "White", "RADIATION_THERAPY": null, "WEIGHT": 62.0, "IN_PANCANPATHWAYS_FREEZE": "Yes", "OS_STATUS": "0:LIVING", "OS_MONTHS": 1.183548673, "DSS_STATUS": "0:ALIVE OR DEAD TUMOR FREE", "DSS_MONTHS": 1.183548673, "DFS_STATUS": null, "DFS_MONTHS": null, "PFS_STATUS": "0:CENSORED", "PFS_MONTHS": 1.183548673, "GENETIC_ANCESTRY_LABEL": "EUR" }, "sample": { "SAMPLE_ID": "TCGA-AX-A3G8-01", "ONCOTREE_CODE": "UEC", "CANCER_TYPE": "Endometrial Cancer", "CANCER_TYPE_DETAILED": "Uterine Endometrioid Carcinoma", "TUMOR_TYPE": "Endometrioid Endometrial Adenocarcinoma", "GRADE": "G3", "TISSUE_PROSPECTIVE_COLLECTION_INDICATOR": "No", "TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR": "Yes", "TISSUE_SOURCE_SITE_CODE": "AX", "TUMOR_TISSUE_SITE": "Uterus", "ANEUPLOIDY_SCORE": 1.0, "SAMPLE_TYPE": "Primary", "MSI_SCORE_MANTIS": 0.9574, "MSI_SENSOR_SCORE": 28.31, "SOMATIC_STATUS": "Matched", "TMB_NONSYNONYMOUS": 26.53333333, "TISSUE_SOURCE_SITE": "Gynecologic Oncology Group", "TBL_SCORE": 8.0 }, "treatments": [] } }